EurekaMag PDF full texts Chapter 31,016

Kunisaki, T.A.; Augenstein, W.L. 1994: Drug- and toxin-induced seizures. Emergency Medicine Clinics of North America 12(4): 1027-1056

Krugh, T.R. 1994: Drug-DNA interactions. Current Opinion in Structural Biology 4(3): 351-364

Souhami, R.L. 1994: Drug-DNA interactions: new discoveries and possibilities for cancer treatment. Quarterly Journal of Medicine 87(4): 195-197

Neidle, S.; Nunn, C.M.; Spink, N.; Jenkins, T.C.; Laughton, C.A.; Wood, A.A. 1995: Drug-DNA sequence recognition in the minor groove. Journal of Biomolecular Structure and Dynamics 12(6): A285

Wenzel, S.L.; Ebener, P.A.; Koegel, P.; Gelberg, L. 1996: Drug-abusing homeless clients in California's substance abuse treatment system. Journal of Psychoactive Drugs 28(2): 147-159

Wise, R.A. 1998: Drug-activation of brain reward pathways. Drug and Alcohol Dependence 51(1-2): 13-22

Hernandez, R.; Colooini, R.; Idoate Garcia, A.; Schutze, E. 1996: Drug-addiction and AIDS in prison population. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Author Eleventh International Conference on AIDS, Vol Two One world: One hope : 501-502

Jiang, J.J.; Driss, F.; Carnot, F.; Thepot, V.; Pol, S.; Brechot, C.; Berthelot, P.; Nalpas, B. 1993: Drug-addiction in a alcoholics A crucial additive risk for viral infections and liver disease. Alcoholism Clinical and Experimental Research 17(2): 510

Pillans, P.I.; Woods, D.J. 1995: Drug-associated alopecia. International Journal of Dermatology 34(3): 149-158

Jick, H. 1995: Drug-associated asymptomatic elevations of transaminase in drug safety assessments. PharmacoTherapy 15(1): 23-25

Katner, S.N.; Coburn, N.; Weiss, F. 1998: Drug-associated discriminative stimuli reinstate alcohol-seeking behavior following an extinction period in rats. Society for Neuroscience Abstracts 24(1-2): 1242

Neuberger, J. 1996: Drug-associated hepatitis. Lam, S -K, Paumgartner, G, Wang, B Falk Symposium; Update on hepatobiliary diseases: 85-98

Frick, T. 1997: Drug-associated pancreatitis Facts and fiction. Pancreas 15(2): 215

Pacher, R.; Bojic, A.; Locker, G.; Roedler, S.; Berger, R.; Frey, B.; Grimm, M.; Laufer, G.; Stanek, B. 1998: Drug-bridging to heart transplantation Effects of prostaglandin E1, prostacyclin and dobutamine A prospective randomized study. European Heart Journal 19(ABST Suppl ): 295

Miescher, P.A.; Favre, H.; Lemoine, R.; Tamagnini, P. 1998: Drug-combination therapy of rheumatoid arthritis. Springer Seminars in Immunopathology 20(1-2): 309-318

Ebert, C.D.; Venkateshwaran, S.; Heiber, W.; Borsadia, S. 1997: Drug-containing adhesive composite transdermal delivery device. Official Gazette of the United States Patent and Trademark Office Patents 1198(1): 336-337

Remunan Lopez, C.; Alonso, M.J.; Bodmeier, R. 1994: Drug-containing chitosan-gelatin microcapsules prepared by complex coacervation. Pharmaceutical Research (New York) 11(10 Suppl): S285

Loftsson, T.; Frioriksdottir, F.; Siguroardottir, A.M.; Stefansson, E. 1996: Drug-cyclodextrin-polymer ternary complexes. European Journal of Pharmaceutical Sciences 4(Suppl ): S144

Bednar, B.; Bednar, R.A.; Cook, J.J.; Bollag, D.M.; Chang, C.T.; Gaul, S.L.; Mcqueney, P.A.; Egbertson, M.S.; Hartman, G.D.; Holahan, M.A.; Lynch, J.J.; Gould, R.J. 1996: Drug-dependent antibodies against GPIIb/IIIa induce thrombocytopenia. Circulation 94(8): I99

Chelladurai, M.; Nayak, B.; Roy, D.; Williams, F.; Boppana, S.; Drelichman, A.; O'connor, M. 1998: Drug-dependent asynchrony of p53 levels and cell death in human renal carcinoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 39: 29

Mosser, A.G.; Rueckert, R.R. 1993: Drug-dependent mutants of sabin poliovirus type 3. Journal of Cellular Biochemistry Suppl 1993(17 Part D): 28

Sultanpur,C.M.; Satyanarayana,S.; Kalaskar,G.P.; Rubbani,S. 2008: Drug-drug interaction between fluvastatin and fenofibrate with gliclazide in rats. Biomed: 3 4, 254-259

Nix, D.E. 1993: Drug-drug interactions with fluoroquinolone antimicrobial agents. Hooper, D C, Wolfson, J S Quinolone antimicrobial agents, Second edition 245-258

Marchbanks, C.R. 1993: Drug-drug interactions with fluoroquinolones. PharmacoTherapy 13(2 Part 2): 23s-28s

Elbarbry, F.A.; Marfleet, T.; Shoker, A.S. 2008: Drug-drug interactions with immunosuppressive agents: review of the in vitro functional assays and role of cytochrome P450 enzymes. Transplantation 85(9): 1222-1229

Groeneveld, P.W.; Matta, M.A.; Greenhut, A.P.; Yang, F. 2008: Drug-eluting compared with bare-metal coronary stents among elderly patients. Journal of the American College of Cardiology 51(21): 2017-2024

Lanzer, P.; Sternberg, K.; Schmitz, K.-P.; Kolodgie, F.; Nakazawa, G.; Virmani, R. 2008: Drug-eluting coronary stent very late thrombosis revisited. Herz 33(5): 334-342

Pfisterer, M.; Bertel, O.; Bonetti, P.O.; Brunner-La Rocca, H.P.; Eberli, F.R.; Erne, P.; Galatius, S.; Hornig, B.; Kiowski, W.; Pachinger, O.; Pedrazzini, G.; Rickli, H.; De Servi, S.; Kaiser, C.; Handke, M.; Buser, P.; Zellweger, M.; Osswald, S.; Hunziker, P.; Kohler, C.; Weilenmann, D.; Joerg, L.; Ammann, P.; Jamshidi, P.; Auer, M.; Dubach, P.; Müller, P.; Moccetti, T.; Fischer, T.; Lindner, M.; Kurz, D.; Friedlingsdorf, J.; Tüller, D.; Zbinden, R.; Amann, W.; Straumann, E.; Maurer, D.; Naegeli, B.; Kyst Madsen, J.; Abildgaard, U.; Galloc, A.; Riis Hansen, P.; Skov Jensen, J.; Kjoeller Hansen, L.; Alber, H.; Urbano, P.; Rickenbacher, P.; Müller, C.; Estlinbaum, W.; Jazurlo, G.; Pedersen, H. 2008: Drug-eluting or bare-metal stents for large coronary vessel stenting? the BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design. American Heart Journal 155(4): 609-614

Fitchett, D., H.; Kutryk, M., B. 2008: Drug-eluting stent thrombosis A lesson in vascular biology. Canadian Journal of Cardiology 24(Suppl C): 50C-55C

Rhee, S.J.; Yun, K.H.; Lee, S.R.; Chae, J.-K.; Nam, C.-W.; Jun, D.-H.; Jeong, J.-W. 2008: Drug-eluting stent thrombosis during perioperative period. International Heart Journal 49(2): 135-142

Panescu, D. 2004: Drug eluting stents. IEEE Engineering in Medicine and Biology Magazine: the Quarterly Magazine of the Engineering in Medicine and Biology Society 23(2): 21-23

Steffel, J.; Eberli, F.R.; Lüscher, T.F.; Tanner, F.C. 2008: Drug-eluting stents - what should be improved?. Annals of Medicine 40(4): 242-252

Hassan, W. 2008: Drug-eluting stents: insights into safety and indications. Annals of Saudi Medicine 28(2): 114-119

Okabe, T.; Lindsay, J.; Buch, A.N.; Steinberg, D.H.; Roy, P.; Slottow, T.L.P.; Smith, K.; Torguson, R.; Xue, Z.; Satler, L.F.; Kent, K.M.; Pichard, A.D.; Weissman, N.J.; Waksman, R. 2008: Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. American Journal of Cardiology 102(5): 530-534

Kelbaek, H.; Thuesen, L.; Helqvist, S.; Clemmensen, P.; Kløvgaard, L.; Kaltoft, A.; Andersen, B.; Thuesen, H.; Engstrøm, T.; Bøtker, H.E.; Saunamäki, K.; Krusell, L.R.; Jørgensen, E.; Hansen, H-Henrik.T.; Christiansen, E.H.; Ravkilde, J.; Køber, L.; Kofoed, K.F.; Terkelsen, C.J.; Lassen, J.F.; Kelbaek, H.; Thuesen, L.; Helqvist, S.; Lassen, J.F.; Clemmensen, P.; Terkelsen, C.J.; Kaltoft, A.; Kløvgaard, L.; Holmvang, L.; Godtfredsen, J.; Andersen, B.; Thuesen, H.; Kofoed, K.F.; Køber, L.; Engstrøm, T.; Bøtker, H.E.; Saunamäki, K.; Krusell, L.R.; Jørgensen, E.; Hansen, H-H.T.; Christiansen, E.H.; Ravkilde, J.; Andersen, H.R.; Kastrup, J.; Kristensen, S.D. 2008: Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial. Circulation 118(11): 1155-1162

Tseng, G.N.; Liang, M.; Ling, S.; Yao, J.A. 1998: Drug-enhanced prepulse potentiation of HERG independent of channel modulation by G-proteins or by protein kinases. Biophysical Journal 74(2 Part 2): A213

Schildcrout, S.A.; Risley, D.S.; Kleemann, R.L. 1992: Drug-excipient interactions of seproxetine maleate hemi-hydrate Isothermal stress methods. Pharmaceutical Research (New York) 9(10 Suppl): S46

Gauthier, I.; Malone, M. 1998: Drug-food interactions in hospitalised patients. Methods of prevention. Drug Safety 18(6): 383-393

Smith, Christine Hamilton 1995: Drug-food/food-drug interactions. Morley, J E, Glick, Z, Rubenstein, L Z Geriatric nutrition: A comprehensive review, Second edition 311-328

Levin, Y.I. 1994: Drug-free time in parkinsonian patients. Zhurnal Nevrologii i Psikhiatrii Imeni S S Korsakova 94(5): 26-28

Emory, E.K.; Schlackman, L.J.; Fiano, K. 1996: Drug-hormone interactions on neurobehavioral responses in human neonates. Infant Behavior and Development 19(2): 213-220

Nyce, J.W. 1997: Drug-induced DNA hypermethylation: a potential mediator of acquired drug resistance during cancer chemotherapy. Mutation Research 386(2): 153-161

Blommaert, F.A.; Michael, C.; Muggia, F.M.; Gill, I.; Schornagel, J.H.; Den Engelse, L. 1993: Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy. Proceedings of the American Association for Cancer Research Annual Meeting 34: 400

Avorn, J.; Bohn, R.; Mogun, H.; Gurwitz, J.; Monane, M.; Everitt, D.; Walker, A. 1992: Drug-induced Parkinsonian symptoms following neuroleptic use. Journal of the American Geriatrics Society 40(10 Suppl): SA5

Gershanik, O.S. 1994: Drug-induced parkinsonism in the aged. Recognition and prevention. Drugs and Aging 5(2): 127-132

Moreau, A.; Dompmartin, A.; Castel, B.; Remond, B.; Leroy, D. 1995: Drug-induced acute generalized exanthematous pustulosis with positive patch tests. International Journal of Dermatology 34(4): 263-266

Larrey, D. 1995: Drug-induced acute hepatitis Causality assessment and clinicopathological manifestations. Gastroenterologie Clinique et Biologique 19(5 Suppl): B57-B62

Frick, T.W.; Speiser, D.E.; Bimmler, D.; Largiadèr, F. 1993: Drug-induced acute pancreatitis: further criticism. Digestive Diseases 11(2): 113-132

Baraldi, A.; Ballestri, M.; Rapana, R.; Leonelli, M.; Lucchi, L.; Furci, L.; Albertazzi, A. 1998: Drug-induced acute renal failure in elderly patients. Nephrology Dialysis Transplantation 13(6): A79

Robinson, T.E.; Badiani, A. 1998: Drug-induced adaptations in catecholamine systems: on the inevitability of sensitization. Advances in Pharmacology 42: 987-990

Ducharme, M.P.; Smythe, M.; Strohs, G. 1993: Drug-induced alterations in serum creatinine concentrations. Annals of PharmacoTherapy 27(5): 622-633

Lo, E.S.; Lin, D.H.; Carvey, P.M. 1994: Drug-induced alterations in striatal neurotrophic activity. Society for Neuroscience Abstracts 20(1-2): 176

Fareed, J.; Hoppenstedt, D.; Bick, R.L.; Bacher, P. 1992: Drug-induced alterations of hemostasis and fibrinolysis. Hematology/Oncology Clinics of North America 6(6): 1229-1245

Bernard, S.; Reichl, S.; Arnhold, J.; Arnold, K. 1998: Drug-induced alterations of the respiratory-burst-oxidase as endpoint of signal transduction in stimulated human neutrophils. European Journal of Haematology 60(5): 325

Raveendran, N.N.; Silver, K.; Freeman, L.C.; Narvaez, D.; Weng, K.; Ganta, S.; Lillich, J.D. 2008: Drug-induced alterations to gene and protein expression in intestinal epithelial cell 6 cells suggest a role for calpains in the gastrointestinal toxicity of nonsteroidal anti-inflammatory agents. Journal of Pharmacology and Experimental Therapeutics 325(2): 389-399

Ohi, H. 1993: Drug-induced aphthoid colitis Report of a case. Stomach and Intestine 28(5): 451-456

Huang, P.; Plunkett, W. 1994: Drug-induced apoptosis Relationship between DNA fragmentation and cell death. Proceedings of the American Association for Cancer Research Annual Meeting 35: 313

Sibayan, S.A.; Latina, M.A.; White, K.; Flotte, T.J. 1996: Drug-induced apoptosis of trabecular meshwork cells. IOVS Investigative Ophthalmology and Visual Science 37(3): S445

Donger, C.; Denjoy, I.; Berthet, M.; Neyroud, N.; Cruaud, C.; Bennaceur, M.; Chivoret, G.; Schwartz, K.; Coumel, P.; Guicheney, P. 1998: Drug-induced arrhythmias associated with a forme fruste long QT syndrome. Journal of Molecular and Cellular Cardiology 30(6): A135

Maignen, F.; Castot, A.; Falcy, M.; Efthymiou, M.L. 1992: Drug-induced aseptic meningitis. Therapie 47(5): 399-402

Davis, B.J.; Thompson, J.; Peimann, A.; Bendixen, B.H. 1994: Drug-induced aseptic meningitis caused by two medications. Neurology 44(5): 984-985

Vekovischeva, O.; Koikkalainen, P.; Korpi, E.R.; Wisden, W. 1998: Drug-induced ataxia in a cerebellar GABA-A receptor subtype-deficient mouse line. Alcoholism Clinical and Experimental Research 22(3 ABSTR Suppl ): 158A

Petz, L.D. 1993: Drug-induced autoimmune hemolytic anemia. Transfusion Medicine Reviews 7(4): 242-254

Penn, A.S.; Low, B.W.; Jaffe, I.A.; Luo, L.; Jacques, J.J. 1998: Drug-induced autoimmune myasthenia gravis. Annals of the new York Academy of Sciences 841: 433-449

Drake, M.J.; Nixon, P.M.; Crew, J.P. 1998: Drug-induced bladder and urinary disorders. Incidence, prevention and management. Drug Safety 19(1): 45-55

Doig, J.C. 1997: Drug-induced cardiac arrhythmias: incidence, prevention and management. Drug Safety 17(4): 265-275

Belegaud, D.; Navarre, C.; Hispard, A.; Castot, A. 1994: Drug-induced cataracts. Therapie 49(5): 465-467

Dianzani, F.; Turriziani, O.; Antonelli, G.; Riva, E.; Simeoni, E.; Cianfriglia, M.; Fattorossi, A. 1994: Drug-induced cell mediated mechanism leading to resistance of HIV to AZT. Antiviral Research 23(Suppl 1): 113

Cabot, M.C.; Giuliano, A.E.; Han, T.Y.; Liu, Y.Y. 1998: Drug-induced ceramide generation and cell death in the absence of sphingomyelin hydrolysis. FASEB Journal 12(8): A1290

Mataga, N.; Imamura, K.; Shiomitsu, T.; Fukamaaauch, F.; Watanabe, Y. 1995: Drug-induced changes in expression of tissue-type plasminogen activator and zif 268 mRNAs in rat visual cortex. Society for Neuroscience Abstracts 21(1-3): 393

Boxt, L.M.; Katz, J.; Reagan, K. 1995: Drug-induced changes in the radiographic appearance of the heart. Seminars in Roentgenology 30(1): 49-61

Metra, M.; Nodari, S.; Raccagni, D.; Garbellini, M.; Grigolato, M.; Rosselli, F.; Dei Cas, L. 1997: Drug-induced changes of exercise capacity correlate with exercise hemodynamics in heart failure. Journal of the American College of Cardiology 29(2 Suppl A): 425A

Metra, M.; Gualeni, A.; Raccagni, D.; Nodari, S.; Dei Cas, L. 1995: Drug-induced changes of peak exercise capacity correlate with peak exercise haemodynamics in chronic heart failure. European Heart Journal 16(ABSTR Suppl ): 153

Taylor, L.D.; Sandberg, J.A.; Patterson, T.; Slikker, W., J. 1996: Drug-induced changes on T and B lymphocyte surface marker expression and proliferation after in vivo administration of the anti-HIV drug 2,3-dideoxyinosine in Sprague Dawley rats. Cellular and Molecular Biology (Noisy-Le-Grand) 42(CONGRESS Suppl ): S30-S31

Ali, S.F.; Kordsmeier, K.J.; Gouch, B. 1993: Drug-induced circling preference in rats Correlation with monoamines levels. Teratology 47(5): 463

Bowen, J.D.; Larson, E.B. 1993: Drug-induced cognitive impairment. Defining the problem and finding solutions. Drugs and Aging 3(4): 349-357

Ranno, A.E.; Potter, J.F.; Morton, J.L. 1996: Drug-induced cognitive impairment in geriatric assessment clinic patients. Journal of the American Geriatrics Society 44(9): S62

Broadway, D. 1997: Drug-induced conjunctival cicatrisation. Developments in Ophthalmology 28: 86-101

Wilhelmus, K.R.; Font, R.L.; Keener, M.J.; Jones, D.B.; Matoba, A.Y. 1994: Drug-induced corneal lipidosis during AIDS A condition simulating microsporidial keratoconjunctivitis. IOVS Investigative Ophthalmology and Visual Science 35(4): 1308

Jain, K.K. 1993: Drug-induced cutaneous vasculitis. Adverse Drug Reactions and Toxicological Reviews 12(4): 263-276

Jeremy, J.Y.; Mikhailidis, D.P. 1997: Drug induced cystitis: the need for vigilance. British Journal of Urology 80(3): 511-512

Mesonero, C.E.; Jugle, J.E. 1992: Drug-induced cytotoxic changes A potential pitfall in bronchioloalveolar lavage specimens. Acta Cytologica 36(4): 589

Su, Y.Z.; Evans, S.S.; Nagourney, R.A. 1994: Drug-induced cytotoxicity in human leukemia 1-0 cultures Molecular and cellular events. Proceedings of the American Association for Cancer Research Annual Meeting 35: 313

Petit, D.L.R.odiere, G.; Sorbette, F.; Montastruc, J.L.; Montastruc, P. 1993: Drug-induced death The experience of the Midi-Pyrenees Pharmacovigilance Center. Therapie 48(2): 161-162

Carter, G.L.; Dawson, A.H.; Lopert, R. 1996: Drug-induced delirium. Incidence, management and prevention. Drug Safety 15(4): 291-301

Starr, J.M.; Whalley, L.J. 1994: Drug-induced dementia. Incidence, management and prevention. Drug Safety 11(5): 310-317

Klysner, R. 1992: Drug-induced depression. Pharmacology and Toxicology 71(Suppl): 107-112

Giuliani, G.C. 1994: Drug-induced depression Anti-hypertensive drugs. Gazzetta Medica Italiana Archivio per le Scienze Mediche 153(5): 189-195

Patten, S.B.; Love, E.J. 1994: Drug-induced depression. Incidence, avoidance and management. Drug Safety 10(3): 203-219

Ganzini, L.; Walsh, J.R.; Millar, S.B. 1993: Drug-induced depression in the aged. what can be done?. Drugs and Aging 3(2): 147-158

Lewis, M.M.; Lawler, C.P.; Nichols, D.E.; Mailman, R.B. 1997: Drug-induced desensitization of the D-1A dopamine receptor dissociates from receptor occupancy and functional efficacy. Society for Neuroscience Abstracts 23(1-2): 1773

Laurent, G.; Bettaieb, A.; Mansat, V.; Levade, T.; Schlaifer, D.; Jaffrezou, J.P. 1997: Drug-induced diacylglycerol production regulates intracellular ceramide concentration, apoptosis and cytotoxicity. Blood 90(10 Suppl 1 Pt 1): 386A

Tanaka, M.; Yoshikawa, T.; Tomita, H. 1994: Drug-induced disorders in taste. Journal of the Japan Pharmaceutical Association 46(12): 1765-1770

Jones, G.; Sambrook, P.N. 1994: Drug-induced disorders of bone metabolism. Incidence, management and avoidance. Drug Safety 10(6): 480-489

Chan, J.C.; Cockram, C.S.; Critchley, J.A. 1996: Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Safety 15(2): 135-157

Pandit, M.K.; Burke, J.; Gustafson, A.B.; Minocha, A.; Peiris, A.N. 1993: Drug-induced disorders of glucose tolerance. Annals of Internal Medicine 118(7): 529-539

Smith, A.G. 1995: Drug-induced disorders of hair and nails. Adverse Drug Reaction Bulletin 1995(173): 655-658

Griffin, J.P. 1992: Drug-induced disorders of taste. Adverse Drug Reactions and Toxicological Reviews 11(4): 229-239

Lexa, F.J. 1995: Drug-induced disorders of the central nervous system. Seminars in Roentgenology 30(1): 7-17

Sliwa, J.A.; Lis, S. 1993: Drug-induced dysphagia. Archives of Physical Medicine and Rehabilitation 74(4): 445-447

Jansen, W.; Frank, J. 1993: Drug-induced exanthema after ingestion of a sweetening agent containing cyclamate and saccharin. Allergologie 16(6): 243-244

Goncharov, Y.N. 1992: Drug-induced exogenous allergic alveolitis. Rossiiskii Meditsinskii Zhurnal 1992(5-12): 59-60

Holohan, P.D.; Larocca, D. 1998: Drug-induced expression of the P-glycoprotein in human kidney cell cultures. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 52A

McWhae, J.A.; Chang, J.; Lipton, J.H. 1992: Drug-induced fatal aplastic anemia following cataract surgery. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 27(6): 313-315

Brea Corral, J.M.; Alfao Olea, A.; Obaldia Alana, M.C.; Martinez Tutor, M.J.; Castano Rodriguez, A.D.; Alonso Zapatero, S. 1993: Drug-induced fever. Farmacia Clinica 10(3): 219-222, 224-250

Graham, D.Y.; Malaty, H.M. 1998: Drug-induced gastric ulcers are caused by more than just NSAIDs Alendronate gastric ulcers. Gastroenterology 114(4 Part 2): A138

Allescher, H.D. 1993: Drug-induced gastrointestinal motility disorders. Verdauungskrankheiten 11(2): 65-73

Hurd, R.; Wilder, B.J. 1992: Drug-induced gingival hyperplasia and hypertrichosis The metal connection. Epilepsia 33(Suppl 3): 107-108

Pernu, H.E.; Knuuttila, M.L.; Huttunen, K.R.; Tiilikainen, A.S. 1994: Drug-induced gingival overgrowth and class Ii major histocompatibility antigens. Transplantation 57(12): 1811-1813

Yeung, V.T.F.; Cockram, C.S. 1993: Drug-induced gynaecomastia and galactorrhoea. Adverse Drug Reaction Bulletin 1993(162): 611-614

Carey, P.J. 1995: Drug-induced haemocytopenias. Adverse Drug Reaction Bulletin 1995(175): 663-666

Tosi, A.; Misciali, C.; Piraccini, B.M.; Peluso, A.M.; Bardazzi, F. 1994: Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Safety 10(4): 310-317

Maulik, N.; Engelman, R.M.; Wei, Z.; Liu, X.; Rousou, J.A.; Flack, J.; Deaton, D.; Das, D.K. 1994: Drug-induced heat shock improves post-ischemic ventricular recovery after cardiopulmonary bypass. Circulation 90(4 Part 2): I423

Døssing, M.; Sonne, J. 1993: Drug-induced hepatic disorders. Incidence, management and avoidance. Drug Safety 9(6): 441-449

Basto, F.; Lopes, V.; Cortez, M.; Pinto, A.; Relvas, S.; Capucho, R. 1993: Drug-induced hepatitis. Journal of Hepatology 18(Suppl 1): S94

De Roos, F.J.; Hoffman, R.S. 1996: Drug-induced hepatotoxicity. New England Journal of Medicine 334(13): 863; Author Reply 864

Andrade, R.J.; Lucena, M.I.; Perez Moreno, J.M.; Fernandez, M.C.; Martin Vivaldi, R.; Ramos Lara, M.; Ferrer Rios, T.; Sanchez Martinez, H.; Bellot, V.; Perez Martinez, J.; De La Mata, M.; Diaz, F.; Diaz Moran, F.; Prieto, J.A.; Martin Herrera, L.; Alcantara, R.; Garcia Escano, M.D.; Lazo, M.D.; Llamas, A.; De 1997: Drug-induced hepatotoxicity Preliminary results from a surveillance program in south Spain. Journal of Hepatology 26(Suppl 1): 297

Lucena, M.I.; Andrade, R.J.; Blanco, E.; Corrales, M.A.; Rodriguez Mendizabal, M.; Cabello, M.R.; Glez Correa, J.A.; Sanchez, D.L.C.esta, F.; Hepatotoxicidad, G.A.daluz Para, E.E.tudio D.L. 1996: Drug-induced hepatotoxicity Results from a database Andalusian Joint Program. Methods and Findings in Experimental and Clinical Pharmacology 18(Suppl C): 87

Merino, N.; Torello, J.; Maiquez, P.; Jimenez, M.C.; Mengibar, A.; Castillo, J.R.Jr 1998: Drug-induced hospital admissions. Methods and Findings in Experimental and Clinical Pharmacology 20(Suppl A): 96

Jensen, G.L. 2008: Drug-induced hyperphagia: what can we learn from psychiatric medications?. Jpen. Journal of Parenteral and Enteral Nutrition 32(5): 578-581

Redondo, P.; de Felipe, I.; de la Peña, A.; Aramendia, J.M.; Vanaclocha, V. 1997: Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine. British Journal of Dermatology 136(4): 645-646

De Leeuw, P.W. 1997: Drug-induced hypertension. Recognition and management in older patients. Drugs and Aging 11(3): 178-185

Arnemo, J.M. 1995: Drug-induced immobilization of normals Just for veterinarians. Norsk Veterinaertidsskrift 107(1): 30

Bertnsen, F.; Kvam, T.; Sorensen, O.J.; Knutsen, K. 1994: Drug-induced immobilization of the brown bear. Norsk Veterinaertidsskrift 106(2): 120-124

Gonzalez, C.A.; Guzman, L.; Nocetti, G. 1998: Drug-induced immune haemolytic anaemia in AIDS patients. Vox Sanguinis 74(Suppl 1): 1437

Lewis, S.M.; Heller, B.A.; Stambolis, V.E. 1992: Drug-induced immune hemolytic anemia in a spinal cord injury patient. Archives of Physical Medicine and Rehabilitation 73(10): 1016

Stroncek, D.F. 1993: Drug-induced immune neutropenia. Transfusion Medicine Reviews 7(4): 268-274

Bougie, D.; Wilker, P.R.; Curtis, B.R.; Aster, R.H. 1998: Drug-induced immune thrombocytopenia induced by ibuprofen. Blood 92(10 Suppl 1 Part 1-2): 180A

Weiss, D.J. 1995: Drug-induced immunomodulation of cytokines. Myers, M J, Murtaugh, M P Cytokines in animal health and disease 203-214

D'Auria, D. 1994: Drug-induced impaired performance. Annals of the Academy of Medicine Singapore 23(5): 760-764

Ennis, M.; Schnabel, M.; Lorenz, W. 1992: Drug-induced interference in fluorometric histamine assays. Agents and Actions 1992(SPEC CONF ISSUE): C177-C180

Sinha, A.M.; Ramachandran, V.; Philomena; Elias, B. 1995: Drug-induced interference of neuro-receptor-mediated cellular signalling processes as an index of neurotoxicity. Journal of Cellular Biochemistry Suppl 1995(19A): 194

Wolf, R.; Elman, M.; Brenner, S. 1993: Drug-induced "intertrigo". International Journal of Dermatology 32(7): 515-516

Carvajal, A.; Alvarez Requejo, A.; H.Martin Arias, L.; Coco, R.; Saavedra, Ja.; Villarroya, M.E.; Herrero, D.; Rueda, C.; Menendez, J.A.; De Deigo, I. 1995: Drug-induced lens opacities A case-control study. Therapie (Paris) 1995(Suppl ): 177

Primka, E.; Gay, D.; Bergfeld, W. 1996: Drug-induced linear IgA disease. Journal of Cutaneous Pathology 23(1): 58

Akhtar, A.; Drew, C.R. 1997: Drug-induced liver disease in elderly patients of a minority population. Gastroenterology 112(4 Suppl): A1208

Fritzler, M.J.; Rubin, R.L. 1993: Drug-induced lupus. Wallace, D Journal Author, Hahn, B H Author Dubois' lupus erythematosus, Fourth edition : 442-453

Pelayo, M.; Vargas, V.; Gonzales, A.; Vallano, A.; Esteban, R.; Guardia, J. 1993: Drug-induced lupus-like reaction and captopril. Annals of PharmacoTherapy 27(12): 1541-1542

Brock, G.B.; Lue, T.F. 1993: Drug-induced male sexual dysfunction. An update. Drug Safety 8(6): 414-426

Peet, M.; Peters, S. 1995: Drug-induced mania. Drug Safety 12(2): 146-153

Ganzini, L.; Millar, S.B.; Walsh, J.R. 1993: Drug-induced mania in the elderly. Drugs and Aging 3(5): 428-435

Wolinsky-Friedland, M. 1995: Drug-induced metabolic bone disease. Endocrinology and Metabolism Clinics of North America 24(2): 395-420

Coleman, M.D.; Coleman, N.A. 1996: Drug-induced methaemoglobinaemia. Treatment issues. Drug Safety 14(6): 394-405

Beaugerie, L.; Luboinski, J.; Brousse, N.; Cosnes, J.; Gendre, J.P.; Chatelet, F.P.; Le Quintrec, Y. 1993: Drug-induced microscopic colitis, with evidence of mucosal immune cell activation. Gastroenterology 104(4 Suppl): A664

Cumberbatch, M.J.; Hefti, F.F.; Hill, R.G.; Hargreaves, R.J. 1997: Drug-induced modulation of dural nociceptive neurotransmission. Society for Neuroscience Abstracts 23(1-2): 1540

Prajda, N.; Shen, F.; Yeh, Y.A.; Singhal, R.L.; Olah, E.; Weber, G. 1996: Drug-induced modulation of inositol 1,4,5-trisphosphate concentration in neoplastic cells. Proceedings of the American Association for Cancer Research Annual Meeting 37: 48-49

Korstanje, M.J. 1995: Drug-induced mouth disorders. Clinical and Experimental Dermatology 20(1): 10-18

Done, A.K. 1994: Drug-induced multiple systems failure. Veterinary and Human Toxicology 36(4): 361

Anmuth, C.J.; Goldberg, G.; Mayer, N.; Sridhara, C.R. 1992: Drug-induced myopathy in a patient with traumatic brain injury. Archives of Physical Medicine and Rehabilitation 73(10): 964

Burns, R.J.; Schultz, D.W. 1993: Drug-induced neurological disorders. Medical Journal of Australia 159(9): 624-626

Mets, T.F. 1995: Drug-induced orthostatic hypotension in older patients. Drugs and Aging 6(3): 219-228

Verhaeverbeke, I.; Mets, T. 1997: Drug-induced orthostatic hypotension in the elderly: avoiding its onset. Drug Safety 17(2): 105-118

Parfitt, A.Michael 1993: Drug-induced osteomalacia. Favus, M J Primer on the metabolic bone diseases and disorders of mineral metabolism, Second edition: 296-300

Underwood, T.W.; Frye, C.B. 1993: Drug-induced pancreatitis. Clinical Pharmacy 12(6): 440-448

Schnyder, B.; Helbling, A.; Kappeler, A.; Pichler, W.J. 1998: Drug-induced papulovesicular exanthema. Allergy 53(8): 817-818

Thompson, D.F. 1993: Drug-induced parotitis. Journal of Clinical Pharmacy and Therapeutics 18(4): 255-258

Apeland, T.; Frøyland, E.S.; Kristensen, O.; Strandjord, R.E.; Mansoor, M.A. 2008: Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins. Epilepsy Research 82(1): 1-6

Kamide, R. 1993: Drug-induced photosensitive skin diseases. Shima, A, Ichahashi, M, Fujiwara, Y, Takebe, H International Congress Series; Frontiers of photobiology: 475-478

Allen, J.E. 1993: Drug-induced photosensitivity. Clinical Pharmacy 12(8): 580-587

Beasley, S.; Araujo, O.E.; Flowers, F.P. 1996: Drug-induced photosensitivity A clinical review. Journal of Pharmacy Technology 12(2): 52-57

Drent, M. 1998: Drug-induced pneumonia associated with hemizygote glucose-6-phosphate-dehydrogenase deficiency. European Journal of Haematology 61(3): 218-220

Chana, P.; Weiser, R.; Obeso, J.A. 1994: Drug-induced psychiatric complications in Parkinsons disease. Neurology 44(4 Suppl 2): A334

Dweik, R.A.; Ahmad, M.; Demeter, S.L. 1997: Drug-induced pulmonary disease. Baum, G L, Crapo, J D, Celli, B R, Karlinsky, J B Textbook of pulmonary diseases, Sixth edition, Vols 1 and 2 477-490

Aronchick, J.M.; Gefter, W.B. 1995: Drug-induced pulmonary disorders. Seminars in Roentgenology 30(1): 18-34

Chetty, K.G.; Ramirez, M.M.; Mahutte, C.K. 1993: Drug-induced pulmonary edema in a patient infected with human immunodeficiency virus. Chest 104(3): 967-969

Izumi, Y.; Someda, H.; Yamazoe, A.; Kamamoto, T.; Fukuzawa, H.; Takaishi, S.; Kanai, M.; Nagata, I. 1996: Drug-induced purpura in a patient with chronic hepatitis C due to interferon therapy. Nihon Shokakibyo Gakkai Zasshi 93(6): 433-436

Pang, B.K.; Su, D.; Ratnam, K.V. 1993: Drug-induced purpura simplex: clinical and histological characteristics. Annals of the Academy of Medicine Singapore 22(6): 870-872

Ward, T.N. 2008: Drug-induced refractory headache. Headache 48(5): 728; Discussion 729

Faul, S.; Link, J. 1993: Drug-induced secondary effects by therapy of osteoporosis. Calcified Tissue International 52(Suppl 1): S80

Alldredge, B.K. 1997: Drug-induced seizures: controversies in their identification and management. PharmacoTherapy 17(5): 857-860

Franson, K.L.; Hay, D.P.; Neppe, V.; Dahdal, W.Y.; Mirza, W.U.; Grossberg, G.T.; Chatel, D.M.; Szwabo, P.A.; Kotegal, S. 1995: Drug-induced seizures in the elderly. Causative agents and optimal management. Drugs and Aging 7(1): 38-48

Ibanez, L.; Perez, E.; Laporte, J.R. 1995: Drug-induced severe acute liver injury in a epidemiological perspective. Therapie (Paris) 1995(Suppl ): 197

Wolkenstein, P.; Revuz, J. 1995: Drug-induced severe skin reactions. Incidence, management and prevention. Drug Safety 13(1): 56-68

Novak, M.; Shapiro, C.M. 1997: Drug-induced sleep disturbances. Focus on nonpsychotropic medications. Drug Safety 16(2): 133-149

Chan, T.Y. 1997: Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management. Drugs and Aging 11(1): 27-44

Thomas, Simon, H.L. 1993: Drug-induced systemic hypertension. Adverse Drug Reaction Bulletin 1993(159): 559-562

Henkin, R.I. 1994: Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Safety 11(5): 318-377

Fuse, H. 1997: Drug-induced testicular damage. Rinsho Hinyokika 51(11): 803-814

Frye, J.L.; Thompson, D.F. 1993: Drug-induced thrombocytosis. Journal of Clinical Pharmacy and Therapeutics 18(1): 45-48

Gittoes, N.J.; Franklyn, J.A. 1995: Drug-induced thyroid disorders. Drug Safety 13(1): 46-55

Sanchez Ramos, J.R.; Weiner, W.J. 1993: Drug-induced tics. Kurlan, R Neurological Disease and Therapy; Handbook of Tourette's syndrome and related tic and behavioral disorders: 183-197

Seligmann, H.; Podoshin, L.; Ben-David, J.; Fradis, M.; Goldsher, M. 1996: Drug-induced tinnitus and other hearing disorders. Drug Safety 14(3): 198-212

Aström-Lilja, C.; Odeberg, J.M.; Ekman, E.; Hägg, S. 2008: Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database. Pharmacoepidemiology and Drug Safety 17(6): 587-592

Castelmur, I.; Eichmann, A.; Kuhn, M. 1992: Drug-induced toxic epidermal necrolysis in Switzerland 1980-1991. Dermatology (Basel) 185(3): 233

Agrawal, N.M.; Dajani, E.Z. 1997: Drug-induced ulcerogenesis. Friedman, G, Jacobson, E D, McCallum, R W Gastrointestinal pharmacology and therapeutics: 55-63

Fraunfelder, F.W.; Rosenbaum, J.T. 1997: Drug-induced uveitis. Incidence, prevention and treatment. Drug Safety 17(3): 197-207

O'Brien, C.B.; Shields, D.S.; Saul, S.H.; Reddy, K.R. 1996: Drug-induced vanishing bile duct syndrome: response to ursodiol. American Journal of Gastroenterology 91(7): 1456-1457

Calabrese, L.H.; Duna, G.F. 1996: Drug-induced vasculitis. Current Opinion in Rheumatology 8(1): 34-40

Gherardini, G.; Gurlek, A.; Evans, G.R.D. 1996: Drug-induced vasodilation after microvascular anastomosis. Microsurgery 17(11): 629

Walther, W.; Stein, U.; Wendt, J.; Shoemaker, R.H. 1996: Drug-inducible retroviral vector for the conditional expression of the human TNF-alpha gene. Proceedings of the American Association for Cancer Research Annual Meeting 37: 350

Segaert, M.F.; De Soete, C.; Vandewiele, I.; Verbanck, J. 1996: Drug-interaction-induced rhabdomyolysis. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 11(9): 1846-1847

Mrozikiewicz, A.; Lowicki, Z.; Kowal, J.; Mrozikiewicz, P.M.; Jablecka, A. 1995: Drug-like activities in healthy human. Therapie (Paris) 1995(Suppl ): 489

Allemann, E.; Gurny, R.; Doelker, E. 1993: Drug-loaded nanoparticles Preparation methods and drug targeting issues. European Journal of Pharmaceutics and Biopharmaceutics 39(5): 173-191

Frost, P.; Bonavida, B. 1998: Drug-mediated immunosensitization of prostate cancer cells to Fas ligand-mediated apoptosis Independence of de novo protein synthesis. FASEB Journal 12(4): A281

Bonavida, B.; Frost, P.; Ng, C.P.; Garban, H.; Mori, S.; Mizutani, Y.; Itakura, M. 1997: Drug-mediated sensitization of resistant tumor cells to Fas-mediated apoptosis Characterization of targeted genes and application in gene therapy. International Journal of Oncology 11(Suppl ): 917

Chevalier, P.; Pilie, R.; Bonnefoy, E.; Kirkorian, G.; Touboul, P. 1995: Drug-mediated torsade de pointes Can we predict the proarrhythmic risk?. European Heart Journal 16(ABSTR Suppl ): 375

Vigh, L.; Toeroek, Z.; Balogh, G.; Gyorfy, Z.; Boros, I.; Duda, E.; Koranyi, L.; Glatz, A.; Maresca, B.; Horvath, I. 1997: Drug-membrane interaction may directly be implicated in the mode of action of the novel HSP co-induced, bimoclomol. Congenital Anomalies 37(4): 378

Baumann, P. 1992: Drug-monitoring and pharmacokinetic tests in Lausanne Current situation and open questions. Laux, G , Riederer, P Plasma level assessment of psychotropic drugs: Therapeutic drug monitoring: Attempt at a first status report Plasmaspiegelbestimmung von Psychopharmaka: Therapeutisches drug-monitoring: Versuch einer ersten Standortbestimmung : 13-16

Hartung, G.; Heeger, S.; Schrenk, H.H.; Stehle, G.; Sinn, H.; Queisser, W. 1996: Drug-monitoring of methotrexate covalently bound to human serum albumin with homogeneous enzyme multiplied immunoassay technique in a Phase I-trial. Annals of Hematology 73(Suppl 2): A50

Johnston, D.; Duffin, D. 1992: Drug-patient interactions and their relevance in the treatment of heart failure. American Journal of Cardiology 70(10): 109c-112c

Bhat, P.G.; Flanagan, D.R.; Donovan, M.D. 1995: Drug-permeation studies through cystic fibrotic mucus solution. Pharmaceutical Research (New York) 12(9 Suppl): S244

Duncan, R. 1995: Drug-polymer conjugates Reduction in anticancer drug toxicity. Zeller, W J , Eisenbrand, G , Hellmann, K Contributions to Oncology; Reduction of anticancer drug toxicity: Pharmacologic, biologic, immunologic and gene therapeutic approaches 170-180

Rohra, D.K.; Das, N.; Azam, S.I.; Solangi, N.A.; Memon, Z.; Shaikh, A.M.; Khan, N.H. 2008: Drug-prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: a cross sectional study. Bmc Pregnancy and Childbirth 8: 24

Johnson, D.J.; Owen, A.; Plant, N.; Bray, P.G.; Ward, S.A. 2008: Drug-regulated expression of Plasmodium falciparum P-glycoprotein homologue 1: a putative role for nuclear receptors. Antimicrobial Agents and ChemoTherapy 52(4): 1438-1445

Somogyi, A.; Müzes, G.; Molnár, J.; Tulassay, Z. 1998: Drug-related Churg-Strauss syndrome?. Adverse Drug Reactions and Toxicological Reviews 17(2-3): 63-74

Hollingsworth, H.M. 1994: Drug-related bronchiolitis obliterans organizing pneumonia. Epler, G R Diseases of the bronchioles 367-376

Wiley 1993: Drug-related Coma in the Adolescent. Adolescent Medicine 4(1): 149-166

Madea, B.; Kaeferstein, H.; Sticht, G. 1994: Drug-related deaths with removal of the corpse. Archiv fuer Kriminologie 193(1-2): 1-9

Major, S.; Badr, S.; Bahlawan, L.; Hassan, G.; Khogaoghlanian, T.; Khalil, R.; Melhem, A.; Richani, R.; Younes, F.; Yeretzian, J.; Khogali, M.; Sabra, R. 1998: Drug-related hospitalization at a tertiary teaching center in Lebanon: incidence, associations, and relation to self-medicating behavior. Clinical Pharmacology and Therapeutics 64(4): 450-461

Davies, P.H. 1997: Drug-related hyperprolactinaemia. Adverse Drug Reactions and Toxicological Reviews 16(2): 83-94

Carpentier, F.; Laville, M.; Leverve, X.; Coulaud, J.M.; Queneau, P. 1997: Drug-related illness in emergency departments A multicentric study. European Journal of Clinical Pharmacology 52(Suppl ): A82

Karagounis, L.A.; Anderson, J.L.; Allen, A.; Osborn, J.S. 1993: Drug-related increases in ventricular refractoriness predicts success, and increases in conduction time predict drug failure in patients undergoing programmed electrical stimulation. Clinical Research 41(2): 118A

Jarenwattananon, M.; Billman, D.; Heimler, R.; Nemeth, P.; Sasidharan, P. 1993: Drug-related isolated intestinal perforation in extremely low birth weight infants. Clinical Research 41(3): 706A

Karran, P.; Bignami, M. 1996: Drug-related killings: a case of mistaken identity. Chemistry and Biology 3(11): 875-879

Wildhagen, K.; Hartung, K.; Hammer, M.; Mau, W.; Schmidt, R.E.; Deicher, H.; Zeidler, H. 1993: Drug-related lupus in a patient with rheumatoid arthritis under sulfasalazine treatment. Clinical Rheumatology 12(2): 265-267

Marx, A.; Schick, M.T.; Minder, C.E. 1994: Drug-related mortality in Switzerland from 1987 to 1989 in comparison to other countries. International Journal of the Addictions 29(7): 837-860

Zuckner, J. 1994: Drug-related myopathies. Rheumatic Diseases Clinics of North America 20(4): 1017-1032

Hewitt, J. 1995: Drug-related unplanned readmissions to hospital. Australian Journal of Hospital Pharmacy 25(5): 400-403

Raschetti, R.; Morgutti, M.; Menniti Ippolito, F.; Popoli, P.; Modigliani, S.; Rossignoli, A.; Longhini, P.; Laguidara, C. 1995: Drug-related visits to an emergency department and hospital admissions. Therapie (Paris) 1995(Suppl ): 190

Vissink, A.; Van Nieuw Amerongen, A.; Wesseling, H.; 's Gravenmade, E.J. 1992: Drug-related xerostomia. Nederlands Tijdschrift voor Tandheelkunde 99(3): 103-107

Girardi, E.; Tronci, M.; Antonucci, G.; Pallotta, G.; Ippolito, G.; Visco, G.; De Mori, P. 1993: Drug-resist tuberculosis and HIV infection in Rome, Italy. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 343

Sedlák, J.; McGown, A.; Hrubisko, M.; Hunáková, L.; Chorváth, B. 1994: Drug-resistance associated alterations of cell surface antigen expression in a human anthracycline-resistant ovarian carcinoma cell line. Neoplasma 41(5): 259-262

Darwich, L.; Esteve, A.; Ruiz, L.; Paredes, R.; Bellido, R.; Cabrera, C.; Romeu, J.; Bofill, M.; Clotet, B.; Martinez-Picado, J. 2008: Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions. Aids Research and Human Retroviruses 24(5): 725-732

Balzarini, J.; Karlsson, A.; De Clercq, E. 1994: Drug-resistant HIV-1 mutants may undergo further mutations in their reverse transcriptase under continuous pressure of HIV-1 specific RT inhibitors. Antiviral Research 23(Suppl 1): 113

Pascual, T.; Gracia Alcalde, M.L.; Alzueta, A.; Orejas, C.; Viejo, G.; Diez Jarilla, J.L. 1998: Drug-resistant Mycobacterium tuberculosis in northern Spain. European Respiratory Journal 12(Suppl 28): 369S

Garin, B.; Di Costanzo, B.; Kassa Kelembho, E.; Legot, B.; Guerin, D.; Ouapou-Lena, F.; Vohito, M.D.; Vincent, V.; Mathiot, C. 1995: Drug-resistant Mycobacterium tuberculosis strains in tuberculosis inpatients in Bangui, Central African Republic. Aids 9(2): 213-214

Patterson, J.E.; Hicks, D.M.; Mcemeel, L.; Crawford, S.; Jorgensen, J.H. 1997: Drug-resistant Streptococcus pneumoniae in the lower Rio Grande Valley, Texas. Abstracts of the General Meeting of the American Society for Microbiology 97: 172

Jack, D.B. 1996: Drug-resistant bacteria: responding to the infectious disease crisis. Molecular Medicine Today 2(12): 499-502

McIvor, R.S. 1996: Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application. Bone Marrow Transplantation 18(Suppl 3): S50-S54

Mills, J.; Safrin, S. 1993: Drug-resistant herpes simplex virus infections The view from the clinical laboratory. Mills, J , Corey, L Antiviral Chemotherapy : 33-40

Longworth, D.L. 1995: Drug-resistant malaria in children and in travelers. Pediatric Clinics of North America 42(3): 649-664

Belch, A.R.; Szczepek, A.J.; Pilarski, L.M. 1997: Drug-resistant malignant B cells in multiple myeloma express CD11b and clonotypic transcripts. Blood 90(10 Suppl 1 Pt 1): 526A

Classen, C.F.; Fulda, S.; Debatin, K.M. 1998: Drug-resistant malignant cells are cross-resistant to perforin/granzyme or CD95-mediated LAK cell kill. Blood 92(10 Suppl 1 Part 1-2): 57B

Watanabe, K.; Anh, D.D.; Huong, P.L.T.; Nguyet, N.T.; Anh, N.T.H.; Thi, N.T.; Dung, N.T.; Phuong, D.M.; Rusizoka, O.S.; Nagatake, T.; Watanabe, H.; Oishi, K. 2008: Drug-resistant pneumococci in children with acute lower respiratory infections in Vietnam. Pediatrics International: Official Journal of the Japan Pediatric Society 50(4): 514-518

Pierallini, A.; Ferone, E.; Bonamini, M.; Bozzao, A.; Quarato, P.P.; Giallonardo, M.T.; Fantozzi, L.M. 1997: Drug-resistant temporal epilepsy MRI signal intensity evaluation with Turbo-FLAIR sequences and volumetric study of hippocampal region. Journal of the Neurological Sciences 150(Suppl ): S237

Salomon, N.; Perlman, D.C.; DePalo, V.A.; Kolokathis, A.; Wilets, I. 1994: Drug-resistant tuberculosis: factors associated with rise in resistance in an HIV-infected urban population. Mount Sinai Journal of Medicine new York 61(4): 341-348

Rieder, H.L. 1994: Drug-resistant tuberculosis: issues in epidemiology and challenges for public health. Tubercle and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 75(5): 321-323

Su, W.J.; Lee, P.Y.; Perng, R.P. 1994: Drug-resistant tuberculosis at Veterans General Hospital-Taipei Trends from 1988 to 1991. Chest 106(2 Suppl): 114S

Mandic, D.; Popovac, D. 1998: Drug-resistant tuberculosis in Belgrade-Yugoslavia. European Respiratory Journal 12(Suppl 28): 369S

Van Der Kuyp, F.; Hirsch, C.S. 1994: Drug-resistant tuberculosis in Cuyahoga County. Chest 106(2 Suppl): 114S

Borchardt, J.; Kirsten, D.; Joerres, R.; Kroeger, C.; Magnussen, H. 1994: Drug-resistant tuberculosis in Germany A retrospective hospital-based study of 1055 cases from 1984 through 1993. European Respiratory Journal 7(Suppl 18): 9S

Djuric, O.; Panjevic, T.; Skodric, V.; Pesic, I. 1994: Drug-resistant tuberculosis in hospitalized patients. Tubercle and Lung Disease 75(Suppl 1): 14

Swanson, D.S.; Starke, J.R. 1995: Drug-resistant tuberculosis in pediatrics. Pediatric Clinics of North America 42(3): 553-581

Salazar, J.C.; Bloom, K.E.; Hostetter, M.K.; Leonardi, C.L. 1996: Drug-resistant tuberculosis verrucosa cutis in a Southeast Asian teenager. Pediatric Infectious Disease Journal 15(9): 834-836

Morre, D.M.; Chueh, P.J.; Wilkinson, F.E.; Morre, D.J. 1996: Drug-responsive NADH oxidase of cultured HeLa cells shed into media and present in sera of cancer patients. Molecular Biology of the Cell 7(Suppl ): 595A

Cho, N.; Caldwell, S.; Cheuh, P.J.; Wu, L.Y.; Morre, D.M.; Morre, D.J. 1997: Drug-responsive NADH oxidase, a new circulating tumor marker. Proceedings of the American Association for Cancer Research Annual Meeting 38: 27

Vandenburgh, H.; Shansky, J.; Benesch-Lee, F.; Barbata, V.; Reid, J.; Thorrez, L.; Valentini, R.; Crawford, G. 2008: Drug-screening platform based on the contractility of tissue-engineered muscle. Muscle and Nerve 37(4): 438-447

Arroyo, M.; Markou, A.; Robbins, T.W.; Everitt, B.J. 1996: Drug-seeking behavior measured using a second-order schedule of IV cocaine reinforcement Effects of withdrawal from free-access to cocaine. Society for Neuroscience Abstracts 22(1-3): 925

Sugimoto, Y.S.tomi Tsukahara; Sato, S.; Tsuruo, T. 1998: Drug-selected coexpression in vivo in hematopoietic cells transduced with MDR1 bicistronic retrovirus vector. Cancer Gene Therapy 5(6 CONF Suppl ): S16

Krauss, G.L.; Campbell, M. 1995: Drug-sensitive patients response to vigabatrin treatment. Epilepsia 36(Suppl 4): 54

Tsutsui, H.; Hasegawa, I. 1993: Drug-specific T cells derived from patients with drug-induced allergic hepatitis. Hepatology 18(4 Part 2): 323A

Saillan-Barreau, C.; Tabbakh, O.; Chavoin, J.-P.; Casteilla, L.; Pénicaud, L. 2008: Drug-specific effect of nelfinavir and stavudine on primary culture of human preadipocytes. Journal of Acquired Immune Deficiency Syndromes 48(1): 20-25

Schiedel, D.; Tucker, J.; Wijsman, J.; Rieder, M.J. 1998: Drug-specific hapten formation during sulphonamide therapy. Clinical and Investigative Medicine: S9

Tashmukhamedov, E.P. 1995: Drug-store service in Uzbekistan, Kazakhstan, and Kirghizia in the Great Patriotic War years. Farmatsiya 44(2): 32-33

Boening, J.; Matern, C.; Fleischmann, H.; Taeschner, K.L.; Jungkunz, G.; Jansen, H.; Budde, G. 1995: Drug-supported prevention of relapse in primary alcoholism with flupentixol-decanoate A multicenter study. Pharmacopsychiatry 28(5): 167

Khossravi, D.; Rork, G.S. 1994: Drug-surfactant interactions Effect on transport properties. Pharmaceutical Research (New York) 11(10 Suppl): S260

Munsiff, S.S.; Driver, C. 1998: Drug-susceptible tuberculosis. Journal of Infectious Diseases 177(4): 1138-1139

Wickboldt, A.; Pagels, P.; Kramer, W.; Wess, G.; Petzinger, E. 1998: Drug-targeting by bile acids Uptake and secretion of bile acid-peptide conjugates to the liver. Naunyn-Schmiedeberg's Archives of Pharmacology 357(4): R8

Marsh, J.; Mukherjee, P.; Seyfried, T.N. 2008: Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet. Nutrition and Metabolism 5: 33

Druger, M. 2006: Drugers Notebook on Science Education Development of Specialists for Teaching Introductory College Science Courses. Journal of natural resources and life sciences education 5(35): 183-184

Schmitt, E.A.; Sun, Y.; Geoffroy, J.M. 1997: Drugexcipient compatibility by isothermal calorimetry Comparison to a traditional HPLC-based technique and actual formulation stability results. Pharmaceutical Research (New York) 14(11 Suppl): S194-S195

Schmitt, E.A. 1997: Drugexcipient compatibility by isothermal calorimetry Identification of experimental conditions. Pharmaceutical Research (New York) 14(11 Suppl): S195

Leroy, D.; Doerig, C. 2008: Drugging the Plasmodium kinome: the benefits of academia-industry synergy. Trends in Pharmacological Sciences 29(5): 241-249

Neri, M. 1993: Drugs Europrovisions for drug advertising. Rivista di Patologia e Clinica 48(3): 129-135

Barber, N. 1993: Drugs: from prescription only to pharmacy only. Bmj 307(6905): 640

Boothe, D.M. 1998: Drugs acting on blood and/or blood forming organs. Veterinary Clinics of North America. Small Animal Practice 28(2): 329-360

Triggle, D.J. 1990: Drugs acting on ion channels and membranes. Emmett, J C (Ed ) Comprehensive Medicinal Chemistry: The Rational Design, Mechanistic Study And Therapeutic Application Of Chemical Compounds, Vol 3 Membranes And Receptors Xvii+1280p Pergamon Press Plc: Oxford, England, Uk; New York, New York, Usa Illus 1047-1100

Verhaeghe, R.; Verstraete, M. 1992: Drugs acting on the cerebral and peripheral circulations. Dukes, M N G Meyler's side effects of drugs: An encyclopedia of adverse reactions and interactions, Twelfth edition: 470-477

Bernardi, M.; Trevisani, F.; Gasbarrini, G. 1990: Drugs acting on the renin angiotensin aldosterone system. Bomzon, A And L M Blendis (Ed ) Cardiovascular Complications Of Liver Disease Ix+374p Crc Press, Inc : Boca Raton, Florida, Usa Illus 337-348

Nagasaka, H.; Miyazaki, T.; Naito, H. 1990: Drugs adsorption characteristics of various dialysis membranes. Japanese Journal of Artificial Organs 19(2): 670-673

Enevoldsen, K. 1993: Drugs affecting autonomic functions of the extrapyramidal system. Dukes, M N G, Aronson, J K Side Effects of Drugs Annual: 144-149, 1992

Rodger, I.W. 1989: Drugs affecting calcium ions in airway smooth muscle. Barnes, P J (Ed) New Drugs For Asthma; Meeting Vii+199p Vch Publishers, Inc : New York, New York, Usa; Ibc Technical Services Ltd : London, England, Uk Illus 45-56

Assmann, G. 1991: Drugs affecting HDL cholesterol. Cardiology 78(3): 236-242

Vasyl'chenko, Y.O.; Lyubartseva, L.A.; Khromova, T.O.; Vasyl'yeva, L.M.; Izmailova, I.K.; Shenhur, V.F.; Kotlyar, V.O. 1991: Drugs affecting metabolic processes in renal diseases. Farmatsevtychnyi Zhurnal (Kiev) 1991(6): 39-44

Spina, D. 1995: Drugs affecting neurotransmitter release in the airways. Pulmonary Pharmacology 8(4-5): 217-225

Margaglione, M.; Grandone, E.; Mancini, F.P.; Di Minno, G. 1996: Drugs affecting plasma fibrinogen levels. Implications for new antithrombotic strategies. Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 46: 169-181

Fuller, R.W. 1990: Drugs affecting serotonin neurons. Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 35: 85-108

Buysse, D.J. 1991: Drugs affecting sleep, sleepiness and performance. Monk, T H Wiley Series in Human Performance and Cognition; Sleep, sleepiness and performance: 249-306

Clark, B.K. 1994: Drugs affecting the parasympathetic nervous system. Kuhn, M A Pharmacotherapeutics: A nursing process approach, Third edition 300-309

Silvestrini, B. 1991: Drugs affecting the serotonergic system. Nappi, G, Bono, G, Sandrini, G, Martignoni, E, Micieli, G Headache and depression: Serotonin pathways as a common clue: 219-224

Kuhn, M.A. 1994: Drugs affecting the sympathetic nervous system. Kuhn, M A Pharmacotherapeutics: A nursing process approach, Third edition 310-333

Capurso, A. 1991: Drugs affecting triglycerides. Cardiology 78(3): 218-225

Shapiro, T.A. 1994: Drugs affecting trypanosome topoisomerases. Advances in Pharmacology 29b: 187-200

al-Nakib, W.; Tyrrell, D.A. 1992: Drugs against rhinoviruses. Journal of Antimicrobial ChemoTherapy 30(2): 115-117

Tarhan, S. 1992: Drugs, anaesthetic agents, and the coronary arteries. Acta Anaesthesiologica Scandinavica. Supplementum 97: 15-21

Correa, M.; Rivas, B.; Somma, V. 1993: Drugs and AIDS in Uruguay. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 824

Zhuuk, O. 1993: Drugs and AIDS in the former Soviet Union Present and future Formulating an approach. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 823

Villain, E. 1993: Drugs and ablation in the treatment of supraventricular tachyarrhythmias in children. Current Opinion in Pediatrics 5(5): 606-610

Davis, M. 1989: Drugs and abnormal liver function tests. Adverse Drug Reaction Bulletin 139: 520-523

Zimmermann, E.; Hausser, D.; Jeangros, C.; Zeugin, P. 1990: Drugs and aids the swiss public opinion. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract 3045

Ternes, T.; Haberer, K. 1998: Drugs and antiseptic agents in surface waters. BAYERISCHES LANDESAMT FUER WASSERWIRTSCHAFT, Munich Contributions to Wastewater Fishery and River Biology; Integrated ecological water assessment: Contents and possibilities, Muenchener Beitraege zur Abwasser- Fischerei- und Flussbiologie; Integrierte oekologische Gewaesserbewertung: Inhalte und Moeglichkeiten 617-627

Kennedy, M. 1994: Drugs and athletes An update. Adverse Drug Reaction Bulletin 1994(169): 639-642

Streufert, S.; Gengo, F.M. 1993: Drugs and behavior An introduction. Streufert, S , Gengo, F M Progress in Basic and Clinical Pharmacology; Effects of drugs on human functioning : 1-12

Kennedy, M.C.; Moran, J.L.; Fearnside, M.; Morris, R.G.; Upton, R.N.; Chivell, W.; Tobin, B. 1996: Drugs and brain death. Medical Journal of Australia 165(7): 394-398

Tobin, B. 1996: Drugs and brain death: a matter of 'practical certainty'. Clinical and Experimental Pharmacology and Physiology 23(8): S44-S46

Moran, J.L. 1996: Drugs and brain death: the clinician's perspective. Clinical and Experimental Pharmacology and Physiology 23(8): S40-S41

Tveite, W.P. 1994: Drugs and breastfeeding. A risk/benefit evaluation. Veterinary and human toxicology 36(Suppl): 1-80

Thoman, M.; Tveite, W.P. 1989: Drugs and breastfeeding an evaluation process to determine the risk benefit ratio to the mother and child. Veterinary and Human Toxicology 31(4): 348

Berlin, C.M. 1989: Drugs and chemicals: exposure of the nursing mother. Pediatric Clinics of North America 36(5): 1089-1097

Gordon, A. 1990: Drugs and criminal behavior. Bluglass, R And P Bowden (Ed ) Principles And Practice Of Forensic Psychiatry Xxi+1405p Longman Group Uk Ltd : Essex, England, Uk; Churchill Livingstone, Inc : New York, New York, Usa Illus 897-902

Jones, K. 1990: Drugs and delivery systems in the management of asthma a uk perspective. Drugs of Today 26(6): 389-397

Seydel, J.K. 1990: Drugs and drug development for chemotherapy of leprosy and tuberculosis including mycobacterium avium infections. Tropical Medicine and Parasitology 4(3): 341-343

Goodwin, S.R. 1991: Drugs and drug reactions. Gravenstein, N (Ed ) Manual Of Complications During Anesthesia Xiii+722p J B Lippincott Co : Philadelphia, Pennsylvania, Usa; London, England, Uk Illus Paper 479-508

Kuzentsov, S.; Mishenko, O.; Polugaevskiy, I.; Bogdanova, J. 1996: Drugs and education of patients in the treatment of severe asthma. Allergy 51(Suppl 32): 75

Millane, T.; Ward, D. 1992: Drugs and exercise testing. Bmj 305(6861): 1043

Liu, Q.; Garner, P.; Wang, Y.; Huang, B.; Smith, H. 2008: Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies. Bmc Public Health 8: 365

Kohnen, R. 1990: Drugs and human social interaction are there sociotropic drug effects. Pharmacology Biochemistry and Behavior 36(2): 430

Donnelly, R.; Morris, A.D. 1994: Drugs and insulin resistance: clinical methods of evaluation and new pharmacological approaches to metabolism. British Journal of Clinical Pharmacology 37(4): 311-320

Kumana, C.R.; Chan, M.K. 1990: Drugs and kidneys. Journal of the Hong Kong Medical Association 42(1): 50-54

Lanni, C.; Aharony, D. 1993: Drugs and lipid mediators workshop. Agents and Actions. Supplements 41: 201-204

Goldstein, P.I.; Sundaram, G.S.; Manimekalai, S. 1990: Drugs and maternal serum alpha fetoprotein. Clinical Chemistry 36(6): 1120

Mihashi, N. 1994: Drugs and menstrual abnormalities. Journal of the Japan Pharmaceutical Association 46(6): 834-835

Lemelson, J.H. 1995: Drugs and methods for treating diseases. Official Gazette of the United States Patent and Trademark Office Patents 1179(2): 936

Ignatov, Y.D.; Zaitsev, A.A. 1991: Drugs and methods of nonopiate analgesia from the point of view of adrenergic pain regulation. Anesteziologiya i Reanimatologiya 3: 65-68

Tsukahara, S. 1992: Drugs and ocular tissues. Nippon Ganka Gakkai Zasshi 96(7): 815-816

Carlson, H.E. 1995: Drugs and pituitary function. Melmed, S The pituitary 645-660

Mikov, M.; Sabo, A.; Jakovljevic, V.; Stanulovic, M.; Banic, B.; Dakovic, K.; Popovic, J.; Sremac, S. 1997: Drugs and poisons information system in medical faculty Novi Sad, Yugoslavia The importance for therapy and medical education. European Journal of Clinical Pharmacology 52(Suppl ): A31

Andrew, M. 1992: Drugs and quality assurance in the hospital Physicians also share the responsibility. Tidsskrift for den Norske Laegeforening 112(18): 2331

Kenakin, T. 1990: Drugs and receptors. An overview of the current state of knowledge. Drugs 40(5): 666-687

Niebyl, J.R. 1991: Drugs and related areas in pregnancy. Zentralblatt für Gynakologie 113(7): 375-388

Barnett, H.J.; Eliasziw, M.; Meldrum, H.E. 1995: Drugs and surgery in the prevention of ischemic stroke. New England Journal of Medicine 332(4): 238-248

Ghebre Sellassie, Isaac 1994: Drugs and the Pharmaceutical Sciences, Vol 65 Multiparticulate oral drug delivery. Ghebre-Sellassie, I Drugs and the Pharmaceutical Sciences; Multiparticulate oral drug delivery ix+480p

Kreuter, J. 1994: Drugs and the Pharmaceutical Sciences, Vol 66 Colloidal drug delivery systems. European Journal of Drug Metabolism and Pharmacokinetics 19(3): 253-256

Weinberg, S. 1995: Drugs and the Pharmaceutical Sciences, Vol 69 Good laboratory practice regulations, Second edition. Weinberg, S Drugs and the Pharmaceutical Sciences; Good laboratory practice regulations, Second edition 223-238

Banker, G.S.; Rhodes, C.T. 1996: Drugs and the Pharmaceutical Sciences, Vol 72 Modern pharmaceutics, Third edition. Banker, G S , Rhodes, C T Drugs and the Pharmaceutical Sciences; Modern pharmaceutics, Third edition 887-906

Chinn, A.B.; Trujillo, K.A. 1996: Drugs and the brain A world wide web tutorial in neuropsychopharmacology. Society for Neuroscience Abstracts 22(1-3): 246

Muir, K.W.; Rodger, J.C.; DeBono, J.S.; McDonald, H.; Irving, J.B. 1992: Drugs and the exercise test. Bmj 305(6857): 808-809

Carnelutti, A. 1990: Drugs and the health professional in the european economic community legal order. Dphm/Inserm (Directeur De La Pharmacie Et Du Medicament/Institut National De La Sante Et De La Recherche Medicale) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale), Vol 213 L'europe Du Medicament: Realites Et Ambitions; (Inserm (National Institute Of Health And Medical Research) Colloquium, Vol 213 Europe And Drugs: Realities And Ambitions); Fourth Colloquium Of The Dphm-Inserm (Director Of Pharmacy And Drugs And National Institute Of Health And Medical Rese

Canonica, G.W.; Scordamaglia, A.; Bagnasco, M.; Ciprandi, G. 1989: Drugs and the immune response: knowledge and perspectives in allergology. Annals of Allergy 62(6): 483-487

Sallie, R.; Tredger, J.M.; Williams, R. 1991: Drugs and the liver. Part 1: Testing liver function. Biopharmaceutics and Drug Disposition 12(4): 251-259

Hartleb, M. 1991: Drugs and the liver. Part II. the role of the antipyrine test in drug metabolism studies. Biopharmaceutics and Drug Disposition 12(8): 559-570

Argov, Z.; Wirguin, I. 1994: Drugs and the neuromuscular junction Pharmacotherapy of transmission disorders and drug-induced myasthenic syndromes. Lisak, R P Neurological Disease and Therapy; Handbook of myasthenia gravis and myasthenic syndromes 295-319

Banker, G.S.; Rhodes, C.T. 1990: Drugs and the pharmaceutical sciences vol 40 modern pharmaceutics second edition. Banker, G S And C T Rhodes Drugs And The Pharmaceutical Sciences, Vol 40 Modern Pharmaceutics, Second Edition Xv+888p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 851-870

Pascoe, P.A. 1994: Drugs and the sleep-wakefulness continuum. Pharmacology and Therapeutics 61(1-2): 227-236

Wellens, Hein, J.J. 1997: Drugs and the ventricular rate in atrial fibrillation Efficacy, limitations, and risks. Murgatroyd, F D , Camm, A J Nonpharmacological management of atrial fibrillation 65-71

Surks, M.I.; Sievert, R. 1995: Drugs and thyroid function. New England Journal of Medicine 333(25): 1688-1694

Pascuzzi, R.M. 1998: Drugs and toxins associated with myopathies. Current Opinion in Rheumatology 10(6): 511-520

Kawaguchi M.; Et Al 1991: Drugs and xerostomia inhibitory mechanisms of benzodiazepines on salivary secretion ii. Shikwa Gakuho 91(11): 1349

Wynn, R.L. 1992: Drugs approved by the FDA in 1991. General Dentistry 40(4): 278-280

Prizont, R.; Mcneil, M.; Talarico, L. 1998: Drugs approved for therapy of inflammatory bowel disease Crohns disease versus ulcerative colitis. Gastroenterology 114(4 Part 2): A1064

Grzybowski, S. 1993: Drugs are not enough. Failure of short-course chemotherapy in a district in India. Tubercle and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 74(3): 145-146

Spitzer, W.O. 1991: Drugs as determinants of health and disease in the population. An orientation to the bridge science of pharmacoepidemiology. Journal of Clinical Epidemiology 44(8): 823-830

Hoffmeister, F. 1990: Drugs as positive reinforcing and punishing stimuli. European Journal of Pharmacology 183(1): 97

Aalykke, C.; Lauritsen, J.M.; Hallas, J.; Laursen, L.S.; Kjeldsen, J.; Lauritsen, K. 1998: Drugs as risk factors for release of inflammatory bowel disease Results of a case-control study. Gastroenterology 114(4 Part 2): A916

Merkel, P.A. 1998: Drugs associated with vasculitis. Current Opinion in Rheumatology 10(1): 45-50

Livshits, V.S.; Zaikov, G.E. 1991: Drugs based on biodestructive polymers review. Khimiko-Farmatsevticheskii Zhurnal 25(1): 15-25

Wagner, H.N.Jr 1990: Drugs behavior and brain chemistry. AJR American Journal of Roentgenology 155(5): 925-931

Manna, G.K. 1991: Drugs boon and or bane. Proceedings of the Zoological Society 44(1): 1-10

Ziment, I. 1989: Drugs breaking mucus polymeric structure enzymes. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 129-136

Ziment, I. 1989: Drugs breaking mucus polymeric structure hypertonic solutions urea and ascorbic acid. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 137-144

Ziment, I. 1989: Drugs breaking mucus polymeric structure thiols cysteine and its derivatives. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 71-76

Trezzi, P. 1989: Drugs breaking mucus polymeric structure thiols mesna. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 119-128

Colombo, F.; Borella, F.; Rampoldi, C.; Zheng, Y. 1989: Drugs breaking mucus polymeric structure thiols thiopronine. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 103-118

Ventresca, G.P.; Cicchetti, V.; Ferrari, V. 1989: Drugs breaking mucus polymeric structures thiols acetylcysteine. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 77-102

Yoshioka, T.; Suzuki, S. 1992: Drugs causing augmentation of ventilation. Kokyu to Junkan. Respiration and Circulation 40(5): 443-450

Donahoo, W.T.; Kosmiski, L.A.; Eckel, R.H. 1998: Drugs causing dyslipoproteinemia. Endocrinology and Metabolism Clinics of North America 27(3): 677-697

Iredale, J.P.; George, C.F. 1993: Drugs causing gastrointestinal obstruction. Adverse Drug Reactions and Toxicological Reviews 12(3): 163-175

Thorne, P.; Byers, D.M.; Palmer, F.B.S.C.; Spence, M.W.; Cook, H.W. 1991: Drugs causing peroxisomal proliferation in vivo inhibit ethanolamine phosphoglyceride synthesis in cultured human fibroblasts. FASEB Journal 5(5): A1154

Jacques Piazza, D.; Diaz, J.; Corallo, J.; Butel, J. 1994: Drugs commission workshop of the CREGG. Acta Endoscopica 24(2 Suppl): 205-207

Trujillo, M.H.; Bellorin-Font, E. 1990: Drugs commonly administered by intravenous infusion in intensive care units: a practical guide. Critical Care Medicine 18(2): 232-238

Cuesta Sanchez, J.; Prieto Marcos, I.; Codesal Martin, L.; Paramo Merchan, A. 1992: Drugs consumption in persons older than 80 years old in a primary rural consultation. Geriatrika 8(7): 64-66

Birrenbach, G.; Juch, R D. 1997: Drugs containing S -ibuprofen. Official Gazette of the United States Patent and Trademark Office Patents 1198(3): 1867

Roskam, W.; Basuyaux, B.; Ferrara, P.; Laporte, M.; Maureaud, T.; Vita, N.; Bayol, A.; Perry, G. 1995: Drugs containing a glycosylated interleukin-2. Official Gazette of the United States Patent and Trademark Office Patents 1174(4): 2600

Franceschini, G.; Paoletti, R. 1993: Drugs controlling triglyceride metabolism. Medicinal Research Reviews 13(2): 125-138

Baskin, L.B.; Parupia, J.Y.; Morgan, D.L.; Ahad, G.V.; Orsulak, P. 1994: Drugs detected in emergency department seizure patients. American Journal of Clinical Pathology 101(3): 387

Auclair, F.; Besnard, M.; Dupont, C.; Wepierre, J. 1990: Drugs distribution in skin after percutaneous absorption importance of blood flow physico chemical properties and absorption rate in bipediculated dorsal flap of hairless rat. Therapie (London/Paris) 45(1)

Sannerstedt, R.; Lundborg, P.; Danielsson, B.R.; Kihlström, I.; Alván, G.; Prame, B.; Ridley, E. 1996: Drugs during pregnancy: an issue of risk classification and information to prescribers. Drug Safety 14(2): 69-77

Belloc, F.; Lacombe, F.; Dumain, P.; Lopez, F.; Bernard, P.; Boisseau, M.R.; Reiffers, J. 1992: Drugs effect on the poly a rna content analysed by in situ hybridization and flow cytometry. Proceedings of the American Association for Cancer Research Annual Meeting 33: 39

Toida, S.; Yasuda, H. 1992: Drugs effects in fibroblast-like cells, may belong to reticuloendothelial system. Journal of Electron Microscopy 41(4): 294

Pascual, C.; González, R.; Romay, C. 1991: Drugs effects on superoxide generation and chemiluminescence response of human leukocytes. Agents and Actions 32(3-4): 277-282

Okudaira, H.; Mori, A. 1998: Drugs for allergic and eosinophilic diseases. Official Gazette of the United States Patent and Trademark Office Patents 1207(4): 2971

Hallstrom, C. 1989: Drugs for anxiety past present and future. Holistic Medicine 4(3): 157-164

Pastushenkov, V.A.; Badyshtov, B.A. 1995: Drugs for better resistance of humans against high ambient temperatures. Meditsina Truda i Promyshlennaya Ekologiya 1995(9): 39-42

Sharma, S. 1993: Drugs for filariasis Four decades of research. Advances in Drug Research 24: 199-260

Aumont, M.C.; Cohen Solal, A.; Himbert, D.; Gourgon, R. 1989: Drugs for heart failure in patients with coronary artery disease. Semaine des Hopitaux 65(38-39): 2369-2371

Packer, M. 1997: Drugs for heart failure that interfere with the renin-angiotensin system. Poole-Wilson, P A, Colucci, W S, Massie, B M, Chatterjee, K, Coats, A J S Heart failure: Scientific principles and clinical practice: 687-700

IIda, T. 1994: Drugs for hemorrhoidal tissue. Journal of the Japan Pharmaceutical Association 46(7): 975-977

Abe, M. 1994: Drugs for hypertension and angina pectoris. Journal of the Japan Pharmaceutical Association 46(8): 45-47

Aursnes, I.; Litleskare, I.; Froyland, H.; Abdelnoor, M. 1995: Drugs for hypertension and risk of acute myocardial infarction. European Heart Journal 16(ABSTR Suppl ): 347

Kitamura, M. 1994: Drugs for micturition. Journal of the Japan Pharmaceutical Association 46(6): 827-828

Sharma, S. 1989: Drugs for parasitic diseases. Drugs of Today 25(4): 249-261

Cedarbaum, J.M.; Schleifer, L.S. 1990: Drugs for parkinsons disease spasticity and acute muscle spasms. Gilman, A G , Et Al Goodman And Gilman's The Pharmacological Basis Of Therapeutics, Eighth Edition Xvii+1811p Pergamon Press: Oxford, England, Uk; New York, New York, Usa Illus 463-484

Horiuchi, K.; Nishimura, T. 1993: Drugs for prostatic hypertrophy. Japanese Journal of Clinical Urology 47(4): 170-171

Kawakubo, T. 1994: Drugs for skin diseases. Journal of the Japan Pharmaceutical Association 46(7): 979-981

Liu, S.S. 1998: Drugs for spinal anesthesia: past, present, and future. Regional Anesthesia and Pain Medicine 23(4): 344-346; Discussion: 384-387

Mariotti, A.; Hefti, A.F. 1997: Drugs for the control of supragingival plaque. Craig, C R, Stitzel, R E Modern pharmacology with clinical applications, Fifth edition: 533-540

Swanson, D.P.; Dick, T.J. 1990: Drugs for the mitigation of internal radiocontamination. Swanson, D P , H M Chilton And J H Thrall Pharmaceuticals in Medical Imaging: Radiopaque Contrast Media, Radiopharmaceuticals, Enhancement Agents For Magnetic Resonance Imaging And Ultrasound Xvi+736p Macmillan Publishing Co : New York, New York, Usa; Collier Macmillan Canada, Inc : London, England, Uk Illus 690-707

Brown, C.G.; Miller, D.D. 1996: Drugs for the treatment of cardiac arrest and other shock states. Official Gazette of the United States Patent and Trademark Office Patents 1187(3): 2040

Obolyentseva, H.V.; Vidyukova, O.I.; Bryuzhinova, L.P.; Zborovs'ka E.O.; Tkalich, L.V. 1990: Drugs for the treatment of diseases of the digestive system. Farmatsevtychnyi Zhurnal (Kiev) (3): 30-34

Garcia-Reboll, L.; Mulhall, J.P.; Goldstein, I. 1997: Drugs for the treatment of impotence. Drugs and Aging 11(2): 140-151

Sasa, M. 1989: Drugs for therapy of dementia an overview. Japanese Journal of Pharmacology 49(Suppl): 16P

Fujiwara, T. 1992: Drugs for treating cataract. Japanese Journal of Clinical Ophthalmology 46(11): 99-102

Kitamura, M. 1994: Drugs for treating diabetes mellitus. Journal of the Japan Pharmaceutical Association 46(7): 981-982

Anon 1992: Drugs for treating hypercholesterolemia fibrates and hmg coa reductase inhibitors and rhabdomyolysis. Journal of the Japan Pharmaceutical Association 44(2): 174-177

Miyaji, M.; Tabeta, H. 1994: Drugs for treating mycosis. Journal of the Japan Pharmaceutical Association 46(5): 627-635

Bays, H.E.; Dujovne, C.A. 1994: Drugs for treatment of patients with high cholesterol blood levels and other dyslipidemias. Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 43: 9-41

Guslandi, M. 1989: Drugs for upper digestive motility disorders. Drugs of Today 25(2): 101-113

Sataloff, R.T. 1991: Drugs for vocal dysfunction. Sataloff, R T Professional Voice: The Science And Art Of Clinical Care Xvii+542p Raven Press: New York, New York, Usa Illus 253-258

Tykhonov O.I.; Yarnykh T.H.; Smyrnova O.S.; Merkur'yeva H.Yu; Budnyikova T.M.; Dadeshydze I.O.; Kotenko O.M.; Filippova L.I.; Bohuts'ka O.Ye; Et Al 1991: Drugs from apiculture products. Farmatsevtychnyi Zhurnal (Kiev) (3): 50-55

Black, J.W. 1989: Drugs from emasculated hormones the principle of syntopic antagonism nobel lecture. Angewandte Chemie International Edition in English 28(7): 886-894

Lefevre, F.; Robe, P.; Jarrin, C.; Ginolhac, Aélien.; Zago, C.; Auriol, D.; Vogel, T.M.; Simonet, P.; Nalin, R. 2008: Drugs from hidden bugs: their discovery via untapped resources. Research in Microbiology 159(3): 153-161

Abdussalam, S. 1990: Drugs from seaweeds. Medical Hypotheses 32(1): 33-35

Anon 1990: Drugs from the rainforest. Naturwissenschaftliche Rundschau 43(10): 432-433

Wallace, R.W. 1997: Drugs from the sea: harvesting the results of aeons of chemical evolution. Molecular Medicine Today 3(7): 291-295

Farrell, M.; Strang, J. 1991: Drugs hiv and prisons time to rethink current policy. British Medical Journal 302(6791): 1477-1478

Parsche, F.; Balabanova, S.; Pirsig, W. 1993: Drugs in ancient populations. Lancet 341(8843): 503

Moraca Sawicki, Anne Marie 1994: Drugs in anesthesia. Kuhn, M A Pharmacotherapeutics: A nursing process approach, Third edition 425-448

Rees, D.C.; Hill, D.R. 1996: Drugs in anesthetic practice. Bristol, J A Annual Reports in Medicinal Chemistry: 41-50

Herrmann, D.B.; Bicker, U. 1990: Drugs in autoimmune diseases. Klinische Wochenschrift 68(Suppl 21): 15-25

Schuetz, I.; Dick, W. 1989: Drugs in cardiopulmonary resuscitation cpr iii atropine. Intensivmedizin und Notfallmedizin 26(2): 111-115

Lowe, G.D. 1990: Drugs in cerebral and peripheral arterial disease. Bmj 300(6723): 524-528

Siest, G.; Galteau, M.M.; Oster, T.; Bayad, J.; Batt, A.M.; Vincent Viry, M.; Balland, M.; Decolin, D.; Wellman, M.; Nicolas, A. 1992: Drugs in clinical chemistry Present situation and future trends. Miyai, K , Kanno, T , Ishikawa, E International Congress Series; Progress in clincal biochemistry : 95-101

Elizur, S.E.; Tulandi, T. 2008: Drugs in infertility and fetal safety. Fertility and Sterility 89(6): 1595-1602

Malone, F.D.; D'Alton, M.E. 1997: Drugs in pregnancy: anticonvulsants. Seminars in Perinatology 21(2): 114-123

McGrath, J.C.; Cowan, D.A. 2008: Drugs in sport. British Journal of Pharmacology 154(3): 493-495

Olivier, S. 1996: Drugs in sport. Justifying paternalism on the grounds of harm. American Journal of Sports Medicine 24(6 Suppl): S43-S45

Kit, V.S.; Neiko, Y.M. 1990: Drugs in the multi modality treatment of gastroduodenal ulcer. Farmatsevtychnyi Zhurnal (Kiev) (4): 28-30

Mcneal, A.P. 1995: Drugs in the nervous system A research-style course for freshmen. Society for Neuroscience Abstracts 21(1-3): 249

Edwards, J.M.; TaylorLloyd, M.Jr.; Porter, J.M. 1997: Drugs in vascular disease. Sidawy, A N, Sumpio, B E, DePalma, R G The basic science of vascular disease: 535-552

Albert, P.; Calverley, P.M.A. 2008: Drugs (including oxygen) in severe COPD. European Respiratory Journal 31(5): 1114-1124

Ferrier, L. 1996: Drugs induced methemoglobinemia. Journal de Pharmacie Clinique 15(1): 27-33

Bastuji Garin, S.; Roujeau, J.C.; Group, B.D.seases French Study 1993: Drugs inducing bullous pemphigoid A case-control study. Journal of Investigative Dermatology 100(4): 540

Bailey, C.J.; Flatt, P.R.; Marks, V. 1989: Drugs inducing hypoglycemia. Pharmacology and Therapeutics 42(3): 361-384

Atobe, O.; Zenda, H. 1990: Drugs inducing urinary disturbance. Rinsho Hinyokika 44(12): 1031-1038

Goldstein, L.B.; Matchar, D.B.; Morgenlander, J.C.; Davis, J.N. 1990: Drugs influence the recovery of function after stroke. Stroke 21(1): 179

Off Drug Aff 1991: Drugs influencing blood sugar values. Journal of the Japan Pharmaceutical Association 43(10): 1228-1229

Kuruvilla, A.; Devi, V. 1994: Drugs influencing cognitive function. Indian Journal of Physiology and Pharmacology 38(4): 241-251

Schiffman, S.S. 1991: Drugs influencing taste and smell perception. Getchell, T V , Et Al (Ed ) Smell And Taste in Health And Disease Xxi+883p Raven Press: New York, New York, Usa Illus 845-850

Schwanstecher, M. 1996: Drugs inhibiting ATP-sensitive K+ channels. Naunyn-Schmiedeberg's Archives of Pharmacology 353(4): R2

Sybertz, E.J. 1990: Drugs inhibiting the metabolism and inactivation of atrial natriuretic factor pharmacological actions and therapeutic implications. Cardiovascular Drug Reviews 8(1): 71-82

Van Zwieten, P.A. 1989: Drugs interacting with alpha adrenoceptors. Cardiovascular Drugs and Therapy 3(2): 121-133

Fiegel, G. 1991: Drugs interacting with anabolic steroids. La Clinica Terapeutica 136(6): 415-420

Lincir, I.; Rosin Grget, K. 1989: Drugs interaction with local anesthetics. Acta Stomatologica Croatica 23(3): 225-230

Solis Recendez, M.G.; Grossin, F.; Bichat, F.; Barbault, H.; Lenaz, L.; Chazard, M.; Khayat, D.; Bastian, G. 1996: Drugs interactions between Taxol and Adriamycin in mice Difference of ADR incorporation according to the schedule of administration. Proceedings of the American Association for Cancer Research Annual Meeting 37: 372

Kariya, K. 1996: Drugs interactions caused by drug metabolizing system. Japanese Journal of Pharmacology 71(Suppl 1): 50P

Powis, G.; Seewald, M.J. 1990: Drugs interfering with growth factor intracellular signaling for the control of cancer cell proliferation. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 2): 1113

Hamring, A. 1991: Drugs licensed for human purposes use in animals some statistical data from sweden. Israel Journal of Entomology 25-26: 323-325

Knowles, G.; Mckeown, M.; Mcculloch, C.A.G. 1990: Drugs mediate regulation of phagocytosis in gingival fibroblasts. Journal of Dental Research 69(Special Issue): 146

Zuliani, G.; Marenco, G.; Daniotti, S. 1989: Drugs modifying mucin biochemistry and mucus secretion bromhexine. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 221-238

D.R.sa G.; Donati, C.; Hodel, C.M. 1989: Drugs modifying mucin biochemistry and mucus secretion domiodol. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 239-250

Ziment, I. 1989: Drugs modifying mucin biochemistry and mucus secretion inorganic and organic iodides. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 251-260

Candiani, C.; Savio, G.C. 1989: Drugs modifying mucin biochemistry and mucus secretion letosteine. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 171-188

Romandini, S. 1989: Drugs modifying mucin biochemistry and mucus secretion sobrerol. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 203-220

Benvenuti, C. 1989: Drugs modifying mucin biochemistry and mucus secretion stepronin. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 189-202

Zavattini, G.; Leproux, G.B.; Daniotti, S. 1989: Drugs modifying the adhesiveness of the gel layer ambroxol. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 263-292

Ziment, I. 1989: Drugs modifying the sol layer and the hydration of mucus. Braga, P C And L Allegra (Ed ) Bronchial Mucology Series: Drugs in Bronchial Mucology Xiv+368p Raven Press: New York, New York, Usa Illus 293-322

Manomiya, Y. 1993: Drugs needed for endoscopic examinations. Japanese Journal of Clinical Urology 47(4): 218-219

Grigson, P.S.; Lyuboslavsky, P.; Tanase, D.; Twining, R.; Freet, C. 1998: Drugs of abuse Conditioned taste aversion or reward comparison. Society for Neuroscience Abstracts 24(1-2): 770

Geller, E.B.; Adler, M.W. 1990: Drugs of abuse and body temperature. Adler, M W And A Cowan (Ed ) Modern Methods in Pharmacology, Vol 6 Testing And Evaluation Of Drugs Of Abuse Xi+297p Wiley-Liss: New York, New York, Usa; Chichester, England, Uk Illus 101-120

Diana, M. 1998: Drugs of abuse and dopamine cell activity. Advances in Pharmacology 42: 998-1001

McGinty, J.F.; Wang, J.Q. 1998: Drugs of abuse and striatal gene expression. Advances in Pharmacology 42: 1017-1019

Zagon, I.S.; Mclaughlin, P.J. 1990: Drugs of abuse and the fetus and neonate testing and evaluation in animals. Adler, M W And A Cowan (Ed ) Modern Methods in Pharmacology, Vol 6 Testing And Evaluation Of Drugs Of Abuse Xi+297p Wiley-Liss: New York, New York, Usa; Chichester, England, Uk Illus 241-254

Friedman, H.; Shivers, S.C.; Klein, T.W. 1994: Drugs of abuse and the immune system. Dean, J H, Luster, M I, Munson, A E, Kimber, I Target Organ Toxicology Series; Immunotoxicology and immunopharmacology, Second edition 303-322

Harchelroad, F.; Clark, R.; Hanlon, D. 1990: Drugs of abuse and the outcome of trauma patients. Veterinary and Human Toxicology 32(4): 344

Stolerman, I. 1992: Drugs of abuse: behavioural principles, methods and terms. Trends in Pharmacological Sciences 13(5): 170-176

Baron, S.P.; Wessinger, W.D.; Wenger, G.R. 1996: Drugs of abuse disrupt memory measured under a delayed matching-to-sample procedure in squirrel monkeys. Society for Neuroscience Abstracts 22(1-3): 1129

Hicks, J.M.; Morales, A.; Soldin, S.J. 1990: Drugs of abuse in a pediatric outpatient population. Clinical Chemistry 36(6): 1256-1257

Wagener, R.E.; Johnson, T.; Stewart, D.; Bibb, K.; Cook, V.; Valdes, R.Jr 1992: Drugs of abuse in an inner city neonatal population. Clinical Chemistry 38(6): 1011

Bosomworth, M.P. 1993: Drugs of abuse in urine: some pitfalls in testing. British Journal of Biomedical Science 50(2): 150-155

Lukas, S.E. 1990: Drugs of abuse in vivo measures of cns excitability. Adler, M W And A Cowan (Ed ) Modern Methods in Pharmacology, Vol 6 Testing And Evaluation Of Drugs Of Abuse Xi+297p Wiley-Liss: New York, New York, Usa; Chichester, England, Uk Illus 121-146

Gallipoli, P.Z.; Ongur, D.; Deutch, A.Y. 1994: Drugs of abuse increase FOS expression in the thalamic paraventricular nucleus. Society for Neuroscience Abstracts 20(1-2): 530

Soderpalm, B.; Pettersson, A.; Shamakina, I.; Andersson, G.; Billig, H.; Engel, J.A. 1997: Drugs of abuse induce C-fos along the mesocorticolimbic dopamine system; focus on ethanol. Society for Neuroscience Abstracts 23(1-2): 2400

Bishop, J.; Douglas, J.; Siegel, N.; Dubler, R.; Wendland, D.; Azzano, C.; Patel, R.; Gardiner, M.; Harrington, C.; Wray, L. 1995: Drugs of abuse monitoring on the Abbott AxSYM system. Clinical Chemistry 41(S6 Part 2): S130

Loh, E.A.; Sardelis, M.; Roberts, D.C.S. 1989: Drugs of abuse produce perseverative behavior in the radial arm maze. Society for Neuroscience Abstracts 15(2): 1187

Coffman, N.B.; Fernandes, J. 1991: Drugs of abuse testing. Journal of the American Osteopathic Association 91(4): 385-388; 395-396

Walczak, M.; Williams, T.; Mohorko, A.; Sayner, B.; Fredericks, D.; Cannon, R.D.; Wong, S.H.Y. 1998: Drugs of abuse testing in a Wisconsin correctional system facility. Clinical Chemistry 44(6 Part 2): A92

Zelikson, Y.I.; Kondrat'eva, T.S. 1992: Drugs of ancient Rome. Farmatsiya 41(6): 87-89

Tolstykh, P.I.; Stekol'nikov L.I.; Ryl'tsev V.V.; Ignatyuk, T.E.; Filatov, V.N.; Karpov, T.S. 1991: Drugs of animal origin for topical use. Khimiko-Farmatsevticheskii Zhurnal 25(4): 83-87

Peters, P.W.; Garbis-Berkvens, H.M.; Bannigan, J.G. 1993: Drugs of choice in pregnancy: primary prevention of birth defects. Reproductive Toxicology 7(5): 399-404

Efremova, I.Ya 1989: Drugs of plant origin manufactured in the ussr and protected by inventors copyright certificates. Rastitel'nye Resursy 25(2): 313-316

Efremova, I.Ya 1990: Drugs of plant origin prepared in the ussr and protected by inventors certificates. Rastitel'nye Resursy 26(2): 291-294

Jadoul, M.; Pirson, Y.; van Ypersele de Strihou, C. 1991: Drugs potentiating cyclosporin nephrotoxicity. Nephron 58(3): 383-384

Nowotny, O.H. 1989: Drugs prices and costs under the magnifying glass. Drugs Made in Germany 32(1): 8-12

Troshin, A.K. 1990: Drugs produced from petroleum. Farmatsiya 39(3): 72-75

Bernini, F.; Corsini, A.; Bellosta, S.; Donetti, E.; Soma, M.; Paoletti, R. 1996: Drugs protecting the arterial wall. Gotto, A M, Jr, Paoletti, R, Smith, L C, Catapano, A L, Jackson, A S Medical Science Symposia Series, Vol 10; Drugs affecting lipid metabolism: Risk factors and future directions: 17-26

Harvengt, C. 1990: Drugs recently released in belgium simvastatin. Acta Clinica Belgica 45(1): 63-65

Berridge, V. 1989: Drugs research: the European dimension. British Journal of Addiction 84(6): 579-580

LozanoA.,M.C.; AriasM.,D.C. 2008: Drugs residues in foods of animal origin actual prospect in Colombia. Revista Colombiana De Ciencias Pecuarias: 1, 121-135

Hileman, G.A.; Neau, S.H.; Upadrashta, S.M. 1994: Drugs solubility effects on water requirements for extrusion and spheronization of high drug-loaded pellets. Pharmaceutical Research (New York) 11(10 Suppl): S132

Hennekens, C.H. 1996: Drugs strategies for treatment of acute and post-MI patients. Gotto, A M, Jr, Paoletti, R, Smith, L C, Catapano, A L, Jackson, A S Medical Science Symposia Series, Vol 10; Drugs affecting lipid metabolism: Risk factors and future directions: 465-471

Clasing, D. 1996: Drugs subject to registration according to the doping definition of the IOC. Deutsche Zeitschrift fuer Sportmedizin 47(6): 390-391

Newman, I.; Marchant, G.J.; Newman, M.L.; Mcmorrow, R. 1990: Drugs suicide and rock and roll. Ohio Journal of Science 90(2): 35

Ehrly, A.M. 1990: Drugs that alter blood viscosity. their role in therapy. Drugs 39(2): 155-159

Magro, C.M.; Crowson, A.N.; Zimarowski, M.J.; Hight, A.M.; Brandes, L.S. 1994: Drugs that bind to novel intracellular histamine receptors as a cause of atypical cutaneous lymphoid hyperplasia. Modern Pathology 7(1): 47A

Alldredge, B.K.; Simon, R.P. 1992: Drugs that can precipitate seizures. Resor, S R Jr And H Kutt (Ed ) Neurological Disease And Therapy, Vol 10 The Medical Treatment Of Epilepsy Xxi+734p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 497-523

Jafri, M.Jr; Burke Wolin, T.; Gurtner, G.H. 1992: Drugs that increase cgmp augment peroxide induced edema formation in isolated rabbit lungs. FASEB Journal 6(5): A1817

Knoblauch, A.L.; Mohassab, K.; Sciuto, A.M.; Merker, A.; Gurtner, G.H. 1990: Drugs that increase cyclic amp attenuate pulmonary vasoconstriction but not thromboxane production during endothelial oxidant challenge. American Review of Respiratory Disease 141(4 Part 2): A489

Dijk, S.N.; Francis, P.T. 1996: Drugs that increase neuronal activity as treatment for Alzheimers disease. Society for Neuroscience Abstracts 22(1-3): 1659

Borchardt Sendek, L.; Kaczkowski, J.; Aiken, J.; Mckenzie, D. 1995: Drugs that increase scrapie incubation period disrupt nucleoprotein complexes in vitro. Journal of Cellular Biochemistry Suppl 1995(21B): 101

Shankar, P.; Serulneck, T.M.; Dezube, B.J.; Lieberman, J. 1997: Drugs that inhibit herpesvirus DNA synthesis block in vitro activation of the Kaposis sarcoma-associated herpes virus in peripheral blood mononuclear cells. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 14(4): A26

Bridges, K.R.; Toth, IIdiko; Leitner, L. 1997: Drugs that produce sideroblastic anemia promote iron-mediated mitochondrial DNA damage. Blood 90(10 Suppl 1 Pt 1): 9A

Malberg, J.E.; Malis, R.W.; Sabol, K.E.; Seiden, L.S. 1994: Drugs that protect against MDMA-induced serotonin neurotoxicity have different effects on body temperature in the rat when administered in combination with MDMA. Society for Neuroscience Abstracts 20(1-2): 290

Clark, B.K. 1994: Drugs that provide pain relief. Kuhn, M A Pharmacotherapeutics: A nursing process approach, Third edition 334-374

Cavalieri, F. 1996: Drugs that target gene expression: an overview. Critical Reviews in Eukaryotic Gene Expression 6(1): 75-85

Kuznetsov, V.V. 1991: Drugs the derivatives of gamma substituted piperidines. Khimiko-Farmatsevticheskii Zhurnal 25(7): 61-75

Wright, G.E. 1997: Drugs to prevent recurrent herpes virus infections. Official Gazette of the United States Patent and Trademark Office Patents 1200(2): 1299-1300

Emanuele, N.V.; Emanuele, M.A. 1995: Drugs to treat the tissue complications of diabetes: peripheral neuropathy. Comprehensive Therapy 21(10): 579-582

Mariko, M. 1991: Drugs: towards sound prescribing and pricing. World Health Forum 12(1): 34-37

Richter Hintz, D.; Sachs, B.; Kronenberg, S.; V.Schmiederberg, S.; Schuppe, H.C.; Ruzicka, T.; Thier, R.; Bolt, H.; Stander, M.; Gleichmann, E.; Esser, C. 1998: Drugs triggering psoriasis and genotype of drug-metabolizing enzymes in patients with psoriasis. Clinical and Investigative Medicine: S28

Benzi, G.; Ceci, A. 1997: Drugs trying to get the parents: there will be incentives for the European scientific community to develop research in the field of the orphan drugs. Pharmacological Research 35(2): 89-93

Miyake, K. 1992: Drugs used after cataract operations Postoperative infections and cystoid macular edema. Japanese Journal of Clinical Ophthalmology 46(11): 103-105

Rayburn, W.F.; Turnbull, G.L. 1993: Drugs used for off-label indications during pregnancy. Teratology 47(5): 433-434

Ames, D.; Chiu, E. 1993: Drugs used for psychiatric disorders. Medical Journal of Australia 159(2): 116-120

Murad, F. 1990: Drugs used for the treatment of angina organic nitrates calcium channel blockers and beta adrenergic antagonists. Gilman, A G , Et Al (Ed ) Goodman And Gilman's The Pharmacological Basis Of Therapeutics, Eighth Edition Xvii+1811p Pergamon Press: Oxford, England, Uk; New York, New York, Usa Illus 764-783

Van Dyke, Knox 1997: Drugs used in acquired immunodeficiency syndrome. Craig, C R, Stitzel, R E Modern pharmacology with clinical applications, Fifth edition: 613-622

Torphy, T.J.; Hay, D.W.P. 1997: Drugs used in asthma. Craig, C R, Stitzel, R E Modern pharmacology with clinical applications, Fifth edition: 491-501

Kern, K.B.; Ewy, G.A. 1992: Drugs used in cardiopulmonary resuscitation. Ewy, G A And R Bressler (Ed ) Cardiovascular Drugs And The Management Of Heart Disease, Second Edition Xvi+496p Raven Press: New York, New York, Usa Illus 455-468

Chren, M.M.; Bickers, D.R. 1997: Drugs used in dermatological disorders. Craig, C R, Stitzel, R E Modern pharmacology with clinical applications, Fifth edition: 519-531

Stier, F.L. 1994: Drugs used in diagnostic testing. Kuhn, M A Pharmacotherapeutics: A nursing process approach, Third edition 151-172

Bavoux, F.; Pariente Khayat, A.; Vauzelle Gardier, C. 1997: Drugs used in gastroesophageal reflux and esophagitis from gastroesophageal reflux Drugs of vagal hyperreflectivity Diphemanil Their side effects. Relier, Journal -P Progress in Neonatology Progres en Neonatologie : 124-164

Seibert, D.G. 1997: Drugs used in gastrointestinal disorders. Craig, C R, Stitzel, R E Modern pharmacology with clinical applications, Fifth edition: 503-518

Van Dyke, Knox 1997: Drugs used in gout. Craig, C R, Stitzel, R E Modern pharmacology with clinical applications, Fifth edition: 471-478

Imbs, J.L.; Welsch, M.; Stephan, D. 1990: Drugs used in hypertension questions and answers. Journal de Medecine de Strasbourg 21(8): 463-464

Messinis, I.E. 1989: Drugs used in in vitro fertilisation procedures. Drugs 38(1): 148-159

Azzaro, A.J.; Ward, H.E. 1997: Drugs used in mood disorders. Craig, C R, Stitzel, R E Modern pharmacology with clinical applications, Fifth edition: 407-420

Rutledge, C.O.; Sonsalla, P.K. 1997: Drugs used in parkinsonism. Craig, C R, Stitzel, R E Modern pharmacology with clinical applications, Fifth edition: 381-389

Mccartney, Patricia Robin 1994: Drugs used in pregnancy, labor and delivery, and abortion. Kuhn, M A Pharmacotherapeutics: A nursing process approach, Third edition 1051-1071

Ziment, I. 1997: Drugs used in respiratory care. Burton, G G, Hodgkin, J E, Ward, J J Respiratory care: A guide to clinical practice, Fourth edition: 469-499

Asch, L. 1996: Drugs used in rheumatic diseases An instructive story. Semaine des Hopitaux 72(19-20): 622-624

Webster, L.T.Jr 1990: Drugs used in the chemotherapy of helminthiasis. Gilman, A G , Et Al (Ed ) Goodman And Gilman's The Pharmacological Basis Of Therapeutics, Eighth Edition Xvii+1811p Pergamon Press: Oxford, England, Uk; New York, New York, Usa Illus 959-977

Webster, L.T.Jr 1990: Drugs used in the chemotherapy of protozoal infections amebiasis giardiasis and trichomoniasis. Gilman, A G , Et Al (Ed ) Goodman And Gilman's The Pharmacological Basis Of Therapeutics, Eighth Edition Xvii+1811p Pergamon Press: Oxford, England, Uk; New York, New York, Usa Illus 999-1007

Webster, L.T.Jr 1990: Drugs used in the chemotherapy of protozoal infections leishmaniasis trypanosomiasis and other protozoal infections. Gilman, A G , Et Al (Ed ) Goodman And Gilman's The Pharmacological Basis Of Therapeutics, Eighth Edition Xvii+1811p Pergamon Press: Oxford, England, Uk; New York, New York, Usa Illus 1008-1017

Webster, L.T.Jr 1990: Drugs used in the chemotherapy of protozoal infections malaria. Gilman, A G , Et Al (Ed ) Goodman And Gilman's The Pharmacological Basis Of Therapeutics, Eighth Edition Xvii+1811p Pergamon Press: Oxford, England, Uk; New York, New York, Usa Illus 978-998

De Natale G.; De Natale F.; Marino A. 1989: Drugs used in the management of peptic ulcer with special reference to h 2 receptor blocking agents. Clinica Terapeutica 129(1): 3-16

Zakrzewska, J.M.; Patsalos, P.N. 1992: Drugs used in the management of trigeminal neuralgia. Oral Surgery Oral Medicine and Oral Pathology 74(4): 439-450

Luddy, E.A.; Sundlof, S.F. 1995: Drugs used in the prevention and treatment of heartworm disease. Soll, M D, Knight, D H Proceedings of the Heartworm Symposium '95: 1-3

Rall, T.W. 1990: Drugs used in the treatment of asthma the methylxanthines cromolyn sodium and other agents. Gilman, A G , Et Al (Ed ) Goodman And Gilman's The Pharmacological Basis Of Therapeutics, Eighth Edition Xvii+1811p Pergamon Press: Oxford, England, Uk; New York, New York, Usa Illus 618-637

Singhal, P.K.; Bhatia, M.S.; Bohra, N.; Dutta, A.K. 1991: Drugs used in the treatment of childhood psychiatric disorders. Indian Pediatrics 28(5): 527-539

Brown, M.S.; Goldstein, J.L. 1990: Drugs used in the treatment of hyperlipoproteinemias. Gilman, A G , Et Al (Ed ) Goodman And Gilman's The Pharmacological Basis Of Therapeutics, Eighth Edition Xvii+1811p Pergamon Press: Oxford, England, Uk; New York, New York, Usa Illus 874-896

Patel, S.; Lyons, A.R.; Hosking, D.J. 1993: Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use. Drugs 46(4): 594-617

Anon 1991: Drugs used in the treatment of patients with endocrine diseases. Problemy Endokria 37(4): 38

Sidorenko, B.A.; Preobrazhenskii, D.V. 1995: Drugs used in treatment of chronic heart failure Part I. Kardiologiya 35(1): 79-92

Sidorenko, B.A.; Preobrazhenskii, D.V. 1995: Drugs used in treatment of chronic heart failure Part II. Kardiologiya 35(2): 81-93

Anarbaeva, R.M.; Ivanova, L.A.; Pavlova, L.A. 1993: Drugs used to treat colpitis. Farmatsiya 42(2): 67-69

Hawkins, D.F. 1989: Drugs used to treat medical disorders in pregnancy and fetal abnormalities. Scarpelli, E M And E V Cosmi (Ed ) Reviews in Perinatal Medicine, Vol 6 Xiii+239p Alan R Liss, Inc : New York, New York, Usa Illus 91-132